Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2007);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Region;Publisher;Coverage;Categories
1;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;11.263;Q1;210;24;69;3600;1654;69;23.83;150;United States;Northern America;Annual Reviews Inc.;1965-1973, 1975-2021;"Pharmacology (Q1); Toxicology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;9.45;Q1;241;16;88;4334;1843;85;19.55;270.88;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1949, 1951-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;20425;Nature Reviews Drug Discovery;journal;14741784, 14741776;7.774;Q1;348;158;818;7071;5339;294;7.01;44.75;United Kingdom;Western Europe;Nature Publishing Group;2002-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
4;24032;Reviews of Physiology Biochemistry and Pharmacology;journal;16175786, 03034240;4.568;Q1;66;7;32;1963;218;32;5.72;280.43;Germany;Western Europe;Springer Verlag;1974-2008, 2012-2018;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
5;22321;Trends in Pharmacological Sciences;journal;18733735, 01656147;4.509;Q1;225;91;327;5036;3123;302;9.19;55.34;United Kingdom;Western Europe;Elsevier Ltd.;1979-2021;"Pharmacology (Q1); Toxicology (Q1)"
6;21195;Pharmacology and Therapeutics;journal;1879016X, 01637258;3.796;Q1;211;111;274;19051;2568;270;8.8;171.63;United States;Northern America;Elsevier Inc.;1975-1977, 1979-1985, 1987-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
7;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;3.265;Q1;233;275;805;25263;4698;801;5.73;91.87;Switzerland;Western Europe;Birkhauser Verlag Basel;1952, 1997-2021;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
8;18017;Neuropsychopharmacology;journal;0893133X, 1470634X;3.143;Q1;227;247;773;15129;4994;741;5.98;61.25;United Kingdom;Western Europe;Nature Publishing Group;1987-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
9;19409;Advanced Drug Delivery Reviews;journal;0169409X, 18728294;3.073;Q1;331;117;371;12760;3224;304;7.83;109.06;Netherlands;Western Europe;Elsevier;1987-2021;Pharmaceutical Science (Q1)
10;20681;Current Opinion in Pharmacology;journal;14714973, 14714892;3.033;Q1;139;98;298;4669;2060;266;6.58;47.64;Netherlands;Western Europe;Elsevier BV;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
11;12611;Drug Resistance Updates;journal;13687646, 15322084;2.935;Q1;119;17;78;2301;602;75;7.15;135.35;United States;Northern America;Churchill Livingstone;1998-2021;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
12;29311;Current Cancer Drug Targets;journal;15680096, 18735576;2.814;Q1;96;79;146;9022;832;143;5.72;114.2;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Cancer Research (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
13;21100456838;Cell Chemical Biology;journal;24519448, 24519456;2.798;Q1;190;159;564;5687;2723;527;4.48;35.77;United States;Northern America;Elsevier Inc.;2016-2021;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
14;26371;Natural Product Reports;journal;02650568, 14604752;2.741;Q1;188;75;138;11288;923;133;6.55;150.51;United Kingdom;Western Europe;Royal Society of Chemistry;1984-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
15;19907;Medicinal Research Reviews;journal;01986325, 10981128;2.645;Q1;134;30;78;5067;642;78;7.64;168.9;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
16;18148;Pain;journal;18726623, 03043959;2.597;Q1;269;315;995;11403;5676;838;5.34;36.2;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1975-2021;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
17;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.568;Q1;146;143;329;7069;1721;310;4.96;49.43;Germany;Western Europe;Springer Verlag;1976-1978, 1980-1981, 1995-2021;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
18;5100155080;Neurotherapeutics;journal;19337213;2.567;Q1;122;80;162;5502;1081;146;6.08;68.78;United States;Northern America;Springer New York;2007-2021;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
19;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.555;Q1;202;351;1254;14027;6278;1251;4.78;39.96;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1965-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
20;12455;Molecular Therapy;journal;15250024, 15250016;2.487;Q1;185;280;705;12038;4098;652;5.99;42.99;United States;Northern America;Cell Press;2000-2021;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
21;21000196010;Topics in antiviral medicine;journal;21615861, 21615853;2.407;Q1;43;22;58;113;306;58;5.95;5.14;United States;Northern America;International Antiviral Society;2011-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q1)"
22;23010;Journal of Controlled Release;journal;18734995, 01683659;2.168;Q1;282;284;1066;11440;5094;1060;4.24;40.28;Netherlands;Western Europe;Elsevier;1984-2021;Pharmaceutical Science (Q1)
23;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.167;Q1;269;768;2405;22398;12006;2301;4.88;29.16;United States;Northern America;American Society for Microbiology;1963-1970, 1972-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
24;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2.119;Q1;276;721;2480;29780;13115;2477;5.11;41.3;United States;Northern America;American Chemical Society;1959-1961, 1963-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
25;20626;Clinical Pharmacology and Therapeutics;journal;15326535, 00099236;2.103;Q1;195;263;415;7750;2628;332;6.09;29.47;United States;Northern America;Wiley-Blackwell;1960-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
26;26795;Controlled Clinical Trials;journal;01972456;2.1;Q1;74;0;47;0;209;40;0;0;Netherlands;Western Europe;Elsevier BV;1980-2004;Pharmacology (Q1)
27;110112;Journal of Immunotherapy;journal;15249557, 15374513;2.06;Q1;97;87;183;3840;931;180;5.06;44.14;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2021;"Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Pharmacology (Q1)"
28;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;2.059;Q1;90;45;162;6068;788;147;4.42;134.84;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology (Q1)"
29;16876;Bioconjugate Chemistry;journal;15204812, 10431802;2.052;Q1;177;280;604;10190;2952;601;4.57;36.39;United States;Northern America;American Chemical Society;1990-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
30;21782;Psychopharmacology;journal;00333158, 14322072;2.029;Q1;202;360;1197;20492;5346;1151;4.19;56.92;Germany;Western Europe;Springer Verlag;1959-2021;Pharmacology (Q1)
31;20435;Neuropharmacology;journal;00283908, 18737064;1.935;Q1;176;275;740;13822;3082;737;3.44;50.26;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;"Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2)"
32;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1.915;Q1;117;32;78;5087;453;72;5.38;158.97;United Kingdom;Western Europe;Informa Healthcare;1971-2021;Toxicology (Q1)
33;26380;Drug and Alcohol Dependence;journal;03768716;1.849;Q1;173;265;518;11726;2088;507;3.64;44.25;Ireland;Western Europe;Elsevier Ireland Ltd;1975-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
34;23916;Environmental Pollution;journal;02697491, 18736424;1.843;Q1;249;465;1042;20498;3801;1031;3.37;44.08;United Kingdom;Western Europe;Elsevier Ltd.;1970-1980, 1986-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
35;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;1.839;Q1;100;52;143;7350;745;137;5.96;141.35;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cancer Research (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
36;23488;Current Medicinal Chemistry;journal;09298673, 1875533X;1.834;Q1;183;261;652;36052;3620;630;5.23;138.13;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1994-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
37;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.818;Q1;113;90;238;4110;902;201;3.46;45.67;United Kingdom;Western Europe;Oxford University Press;1998-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
38;4400151524;Particle and Fibre Toxicology;journal;17438977;1.812;Q1;105;11;30;555;230;29;8.07;50.45;United Kingdom;Western Europe;BioMed Central Ltd.;2004-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
39;145164;Human Genomics;journal;14739542, 14797364;1.791;Q1;59;0;91;0;271;78;2.38;0;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2006, 2008-2021;"Drug Discovery (Q1); Genetics (Q1); Molecular Medicine (Q1); Molecular Biology (Q2)"
40;12331;Current Topics in Medicinal Chemistry;journal;15680266, 18734294;1.782;Q1;122;190;419;13804;1793;360;4.22;72.65;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
41;20682;Current Pharmaceutical Design;journal;13816128, 18734286;1.781;Q1;166;337;1056;38981;4999;939;4.93;115.67;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1995-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
42;130044;Pharmacogenetics and Genomics;journal;17446880, 17446872;1.763;-;144;111;307;4356;1813;302;5.39;39.24;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2005-2021;"Genetics (clinical) (Q1); Molecular Medicine (Q1); Genetics (Q2); Molecular Biology (Q2)"
43;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;1.744;Q1;203;510;1394;12143;5691;1164;4.09;23.81;United Kingdom;Western Europe;Oxford University Press;1975-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
44;20084;British Journal of Pharmacology;journal;14765381, 00071188;1.728;Q1;223;407;1195;19277;4977;1171;3.9;47.36;United States;Northern America;Wiley-Blackwell;1965-2021;Pharmacology (Q1)
45;21790;Antiviral Therapy;journal;20402058, 13596535;1.704;Q1;89;149;371;6331;1562;360;4.01;42.49;United Kingdom;Western Europe;International Medical Press Ltd;1996-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
46;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.697;Q1;233;549;1890;20899;8042;1881;4.26;38.07;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1945-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
47;20063;Biochemical Pharmacology;journal;18732968, 00062952;1.692;Q1;206;372;1195;18117;5167;1140;4.37;48.7;United States;Northern America;Elsevier Inc.;1958-2021;"Biochemistry (Q1); Pharmacology (Q1)"
48;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1.666;Q1;115;183;408;10010;1524;404;3.42;54.7;Netherlands;Western Europe;Springer Netherlands;1996-2021;"Biochemistry (medical) (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cancer Research (Q2); Cell Biology (Q2)"
49;26512;Tetrahedron;journal;14645416, 00404020;1.648;Q1;226;1343;3739;65976;11333;3712;2.97;49.13;United Kingdom;Western Europe;Elsevier Ltd.;1957-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
50;15576;European Neuropsychopharmacology;journal;0924977X, 18737862;1.623;Q1;118;105;261;5078;1128;256;4.4;48.36;Netherlands;Western Europe;Elsevier;1990-2021;"Biological Psychiatry (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
51;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.601;Q1;163;234;627;10481;2456;618;3.77;44.79;United States;Northern America;American Chemical Society;1988-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
52;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863, 2162660X;1.517;Q1;76;13;36;1996;152;36;2.63;153.54;United States;Northern America;Begell House Inc.;1984-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
53;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;18733441, 09396411;1.505;Q1;168;191;406;6043;1574;399;3;31.64;Netherlands;Western Europe;Elsevier;1991-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
54;18922;Journal of Gene Medicine;journal;1099498X, 15212254;1.492;Q1;94;101;443;4088;1871;442;3.8;40.48;United States;Northern America;John Wiley and Sons Ltd;1998-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2)"
55;28792;Cancer Biology and Therapy;journal;15384047, 15558576;1.489;Q1;120;324;986;10545;1822;627;1.87;32.55;United States;Northern America;Landes Bioscience;2002-2021;"Oncology (Q1); Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
56;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.488;Q1;100;43;114;3050;545;112;4.22;70.93;United States;Northern America;Informa Healthcare;1972-2021;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
57;16088;Journal of Nanobiotechnology;journal;14773155;1.469;Q1;84;11;35;442;201;35;3.43;40.18;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2021;"Applied Microbiology and Biotechnology (Q1); Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
58;20677;Current Opinion in Drug Discovery and Development;journal;13676733;1.46;Q1;81;74;218;3851;884;202;3.82;52.04;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
59;25218;Toxicological Sciences;journal;10960929, 10966080;1.459;Q1;193;317;950;13951;4028;923;4.02;44.01;United Kingdom;Western Europe;Oxford University Press;1981-2021;Toxicology (Q1)
60;26514;Tetrahedron Letters;journal;00404039, 18733581;1.448;Q1;173;1969;6032;60667;16395;6031;2.74;30.81;United Kingdom;Western Europe;Elsevier Ltd.;1959-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
61;22072;Current Gene Therapy;journal;18755631, 15665232;1.447;Q1;75;42;144;4712;667;139;4.92;112.19;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
62;20664;Current Drug Targets;journal;18735592, 13894501;1.433;Q1;107;137;323;15626;1332;290;4.13;114.06;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
63;21354;Expert Opinion on Therapeutic Targets;journal;14728222, 17447631;1.433;Q1;94;134;227;13332;751;212;3.36;99.49;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
64;4000148203;Handbook of Experimental Pharmacology;journal;01712004;1.431;Q1;96;87;338;7670;665;329;1.97;88.16;Germany;Western Europe;Springer Heidelberg;2004-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry (Q2)"
65;20624;Clinical Pharmacokinetics;journal;11791926, 03125963;1.429;Q1;169;68;241;4519;1288;232;4.86;66.46;United Kingdom;Western Europe;Adis International Ltd;1976-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
66;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.417;Q1;159;266;802;12540;2721;790;3.32;47.14;United States;Northern America;Wiley-Blackwell;1977-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
67;23109;Journal of Psychopharmacology;journal;14617285, 02698811;1.415;Q1;121;108;345;4900;1168;303;3.31;45.37;United Kingdom;Western Europe;SAGE Publications Ltd;1987-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
68;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.414;Q1;182;302;752;9681;3177;743;3.93;32.06;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1973-2021;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
69;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.409;Q1;96;97;187;3044;532;180;3.05;31.38;United Kingdom;Western Europe;Nature Publishing Group;2006-2021;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
70;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.407;Q1;175;294;869;14406;3545;858;3.56;49;United States;Northern America;Academic Press Inc.;1959-2021;"Pharmacology (Q1); Toxicology (Q1)"
71;20758;Current Drug Targets: Inflammation and Allergy;journal;1568010X;1.399;Q1;51;0;145;0;573;132;4.1;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2002-2005;"Immunology and Allergy (Q1); Pharmacology (Q1); Immunology (Q2)"
72;20663;Current Drug Metabolism;journal;18755453, 13892002;1.367;Q1;111;76;150;8173;833;144;4.88;107.54;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1)"
73;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.363;Q1;213;231;813;10923;3011;806;3.34;47.29;United States;Northern America;Springer New York;1984-2021;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Molecular Medicine (Q2)"
74;23155;Current Vascular Pharmacology;journal;15701611, 18756212;1.362;Q1;63;33;116;3168;478;111;4.49;96;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2003-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1)"
75;21196;Drug Discovery Today;journal;18785832, 13596446;1.362;Q1;185;148;752;7463;2668;626;4.31;50.43;United Kingdom;Western Europe;Elsevier Ltd.;1996-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
76;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.356;Q1;129;109;339;4466;914;324;2.42;40.97;United States;Northern America;Alcohol Research Documentation, Inc.;2007-2021;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
77;29845;IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer;book series;10171606;1.335;Q1;48;14;27;4907;96;27;1.1;350.5;France;Western Europe;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-2020;"Toxicology (Q1); Cancer Research (Q2)"
78;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.305;Q1;90;43;157;2569;745;146;5.37;59.74;United Kingdom;Western Europe;Nature Publishing Group;2001-2021;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
79;20104;CNS Drug Reviews;journal;1080563X, 15273458;1.292;Q1;61;26;68;2174;254;66;3.91;83.62;United States;Northern America;Neva Press, Inc.;1995-2007;"Pharmacology (Q1); Neuropsychology and Physiological Psychology (Q2)"
80;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;18784216, 02785846;1.291;Q1;134;273;555;11234;1887;535;3.33;41.15;United States;Northern America;Elsevier Inc.;1982-2022;"Pharmacology (Q1); Biological Psychiatry (Q2)"
81;130126;Molecular Pharmaceutics;journal;15438384, 15438392;1.277;Q1;138;96;201;4563;761;188;3.84;47.53;United States;Northern America;American Chemical Society;2004-2021;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2)"
82;23053;Journal of Natural Products;journal;01633864, 15206025;1.255;Q1;147;406;1220;10111;3450;1214;2.79;24.9;United States;Northern America;American Chemical Society;1949, 1971, 1973, 1978-2021;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
83;25125;Journal of Analytical Toxicology;journal;19452403, 01464760;1.252;Q1;78;97;363;2104;789;348;2.1;21.69;United States;Northern America;Preston Publications;1977-2021;"Analytical Chemistry (Q1); Chemical Health and Safety (Q1); Environmental Chemistry (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
84;29712;Clinical Therapeutics;journal;1879114X, 01492918;1.247;Q1;140;296;592;9610;2460;531;3.89;32.47;United States;Northern America;Elsevier Inc.;1977-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
85;21237;Drug Safety;journal;01145916, 11791942;1.235;Q1;131;108;273;4980;1088;248;3.73;46.11;United Kingdom;Western Europe;Adis International Ltd;1990-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
86;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;1.235;Q1;51;30;32;2674;91;28;2.84;89.13;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2015;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Immunology (Q2); Immunology and Allergy (Q2)"
87;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085, 1873264X;1.222;Q1;133;547;1370;14026;3938;1363;2.8;25.64;Netherlands;Western Europe;Elsevier;1983-2022;"Analytical Chemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q2)"
88;23079;Journal of Pharmaceutical Sciences;journal;15206017, 00223549;1.2;Q1;186;283;779;11660;2481;734;3.09;41.2;United States;Northern America;"John Wiley &amp; Sons Inc.";1961-2021;Pharmaceutical Science (Q1)
89;20049;Behavioural Pharmacology;journal;14735849, 09558810;1.194;Q1;83;84;218;4643;574;208;2.5;55.27;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1992-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
90;21351;Expert Opinion on Investigational Drugs;journal;13543784, 17447658;1.19;Q1;109;170;411;12057;1505;390;3.85;70.92;United Kingdom;Western Europe;Taylor and Francis Ltd.;1994-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
91;22454;International Journal of Pharmaceutics;journal;18733476, 03785173;1.186;Q1;229;529;1406;16402;4391;1394;2.77;31.01;Netherlands;Western Europe;Elsevier;1978-2021;Pharmaceutical Science (Q1)
92;25789;Bioorganic Chemistry;journal;00452068, 10902120;1.164;Q1;66;38;117;1415;282;114;2.08;37.24;United States;Northern America;Academic Press Inc.;1971-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2); Molecular Biology (Q3)"
93;4600151527;Infectious Disorders - Drug Targets;journal;18715265;1.158;Q1;55;35;89;3848;267;83;2.93;109.94;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Microbiology (medical) (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
94;4700152457;Nano Today;journal;17480132;1.149;Q1;155;43;24;1918;78;16;3.25;44.6;Netherlands;Western Europe;Elsevier;1970, 2006-2021;"Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Nanoscience and Nanotechnology (Q2)"
95;24749;Addiction Biology;journal;13556215, 13691600;1.142;Q1;83;36;114;2655;317;100;2.8;73.75;United States;Northern America;Wiley-Blackwell;1996-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
96;22477;Investigational New Drugs;journal;01676997, 15730646;1.131;Q1;90;70;183;1837;568;180;3.32;26.24;Netherlands;Western Europe;Kluwer Academic Publishers;1983-2021;"Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
97;21165;PharmacoEconomics;journal;11707690, 11792027;1.129;Q1;104;84;368;3733;991;318;2.45;44.44;United Kingdom;Western Europe;Adis International Ltd;1992-2021;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
98;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;1.126;Q1;154;1302;3488;32470;9449;3487;2.79;24.94;United Kingdom;Western Europe;Elsevier Ltd.;1991-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
99;144771;Clinical Trials;journal;17407753, 17407745;1.119;Q1;67;60;177;1519;289;162;1.65;25.32;United Kingdom;Western Europe;SAGE Publications Ltd;2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
100;24797;Mini-Reviews in Medicinal Chemistry;journal;18755607, 13895575;1.113;Q1;95;114;339;11701;1180;322;3.3;102.64;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
101;21197;Pharmacology Biochemistry and Behavior;journal;00913057, 18735177;1.095;Q1;139;176;814;9717;2155;811;2.58;55.21;United States;Northern America;Elsevier Inc.;1973-2021;"Pharmacology (Q1); Toxicology (Q1); Biochemistry (Q2); Biological Psychiatry (Q2); Clinical Biochemistry (Q2); Behavioral Neuroscience (Q3)"
102;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;1.094;Q1;115;151;428;6058;839;428;1.78;40.12;United States;Northern America;Springer New York;1973-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
103;13250;Expert Opinion on Biological Therapy;journal;14712598, 17447682;1.092;Q1;91;165;428;13835;1366;425;3.09;83.85;United Kingdom;Western Europe;Taylor and Francis Ltd.;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1); Clinical Biochemistry (Q2)"
104;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;1.089;Q1;87;164;585;5227;1588;576;2.73;31.87;Japan;Asiatic Region;Japanese Pharmacological Society;1996-2021;"Pharmacology (Q1); Molecular Medicine (Q2)"
105;18071;Neurotoxicity Research;journal;14763524, 10298428;1.087;Q1;78;46;169;4442;536;168;3.32;96.57;United States;Northern America;Springer New York;1999, 2001-2021;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
106;24763;Addictive Behaviors;journal;03064603;1.083;Q1;135;300;602;8906;1524;601;2.17;29.69;United Kingdom;Western Europe;Elsevier Ltd.;1975-2022;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
107;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.083;Q1;89;17;54;3595;192;50;2.78;211.47;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
108;84948;Expert Opinion on Drug Delivery;journal;17425247;1.077;Q1;116;55;162;4415;508;155;2.95;80.27;United Kingdom;Western Europe;Taylor and Francis Ltd.;2004-2021;Pharmaceutical Science (Q1)
109;21825;Reviews in Contemporary Pharmacotherapy;journal;09548602;1.077;Q1;17;0;1;0;3;1;0;0;United Kingdom;Western Europe;Marius Press;1996-2004;Pharmacology (Q1)
110;27823;Alimentary Pharmacology and Therapeutics, Supplement;journal;09530673;1.069;Q1;66;0;184;0;633;177;2.94;0;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1991, 1993-2005;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
111;19617;Antiviral Research;journal;01663542, 18729096;1.064;Q1;134;114;285;4393;1011;283;3.82;38.54;Netherlands;Western Europe;Elsevier;1959, 1981-2021;"Pharmacology (Q1); Virology (Q2)"
112;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;1.062;Q1;171;719;2098;26643;5886;2094;2.78;37.06;United Kingdom;Western Europe;Elsevier Ltd.;1993-2021;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
113;29097;Cancer Chemotherapy and Pharmacology;journal;14320843, 03445704;1.053;Q1;114;193;564;6080;1562;560;2.8;31.5;Germany;Western Europe;Springer Verlag;1978-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)"
114;25219;Toxicology;journal;0300483X, 18793185;1.053;Q1;165;299;890;12853;2857;877;3.18;42.99;Ireland;Western Europe;Elsevier Ireland Ltd;1959, 1973-2021;Toxicology (Q1)
115;19034;Microbial Drug Resistance;journal;10766294, 19318448;1.042;Q1;72;43;156;1347;326;156;1.9;31.33;United States;Northern America;Mary Ann Liebert Inc.;1995-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Immunology (Q2); Microbiology (Q2); Microbiology (medical) (Q2)"
116;18073;NeuroToxicology;journal;18729711, 0161813X;1.036;Q1;122;162;335;6672;1060;319;3.17;41.19;Netherlands;Western Europe;Elsevier;1979-2021;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
117;20679;Current Opinion in Investigational Drugs;journal;20403429, 14724472;1.033;Q1;79;113;438;6943;1261;406;3.02;61.44;United Kingdom;Western Europe;Current Drugs Ltd.;2000-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
118;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;1.017;Q1;76;76;159;3580;357;157;2.17;47.11;United States;Northern America;Elsevier Inc.;1996, 1998-2021;"Pharmacology (Q1); Biochemistry (Q2); Physiology (Q2); Cell Biology (Q3)"
119;21333;European Journal of Pharmacology;journal;00142999, 18790712;1.002;Q2;189;740;2146;28348;6181;2138;2.63;38.31;Netherlands;Western Europe;Elsevier;1967-2021;Pharmacology (Q2)
120;17595;Journal of Biomolecular Screening;journal;10870571, 1552454X;0.998;Q1;79;108;253;2743;676;251;2.45;25.4;United States;Northern America;SAGE Publications Inc.;1996-2017;"Drug Discovery (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Biotechnology (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
121;21169;Pharmacological Research;journal;10436618, 10961186;0.986;Q2;147;134;429;8239;1331;423;2.99;61.49;United States;Northern America;Academic Press Inc.;1989-2021;Pharmacology (Q2)
122;20680;Current Opinion in Molecular Therapeutics;journal;14648431;0.985;Q1;66;72;238;4448;601;213;2.53;61.78;United Kingdom;Western Europe;Current Drugs Ltd.;1999-2010;"Drug Discovery (Q1); Molecular Medicine (Q2); Pharmacology (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3)"
123;21455;Progress in Medicinal Chemistry;journal;00796468, 18757863;0.981;Q2;36;5;23;777;53;20;2.88;155.4;Netherlands;Western Europe;Elsevier;1961-1963, 1965, 1967, 1969-2021;"Molecular Medicine (Q2); Pharmacology (Q2)"
124;21841;Food Additives and Contaminants;journal;0265203X, 14645122;0.975;Q1;102;166;444;5247;1118;437;2.35;31.61;United Kingdom;Western Europe;Taylor and Francis Ltd.;1984-2008;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Health, Toxicology and Mutagenesis (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1)"
125;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.974;Q2;96;151;431;5734;1114;429;2.68;37.97;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1990-2021;"Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2); Pharmacology (Q2)"
126;21167;Pharmacogenomics;journal;14622416, 17448042;0.973;Q2;94;171;302;8444;1014;273;3.29;49.38;United Kingdom;Western Europe;Future Medicine Ltd.;2000-2021;"Molecular Medicine (Q2); Pharmacology (Q2); Genetics (Q3)"
127;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484, 19404034;0.97;Q2;52;34;122;1317;230;111;1.94;38.74;United Kingdom;Western Europe;SAGE Publications Ltd;1996-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
128;14144;Experimental and Clinical Psychopharmacology;journal;19362293, 10641297;0.964;Q2;95;60;124;3417;300;123;2.29;56.95;United States;Northern America;American Psychological Association;1993-2021;"Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Pharmacology (Q2)"
129;130025;Current Drug Delivery;journal;15672018;0.959;Q1;65;35;129;2110;419;127;3.2;60.29;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Pharmaceutical Science (Q1)
130;22378;Vascular Pharmacology;journal;18793649, 15371891;0.959;Q2;100;107;233;4006;597;225;2.71;37.44;United States;Northern America;Elsevier Inc.;2002-2021;"Molecular Medicine (Q2); Pharmacology (Q2); Physiology (Q2)"
131;4700152612;Current Nanoscience;journal;15734137;0.958;Q1;47;39;35;2293;81;33;2.31;58.79;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Biotechnology (Q2); Nanoscience and Nanotechnology (Q2)"
132;24652;Chemico-Biological Interactions;journal;00092797;0.957;Q1;128;149;420;6016;1225;416;2.83;40.38;Ireland;Western Europe;Elsevier Ireland Ltd;1969-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
133;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0.957;Q1;95;74;210;3144;502;198;2.19;42.49;United Kingdom;Western Europe;Informa Healthcare;1986-1987, 1992-2021;Pharmaceutical Science (Q1)
134;20602;Clinical Neuropharmacology;journal;1537162X, 03625664;0.955;Q2;80;59;197;1465;597;186;2.78;24.83;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1982-2021;"Pharmacology (medical) (Q1); Neurology (clinical) (Q2); Pharmacology (Q2)"
135;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;0.953;Q2;70;39;93;1821;237;87;2.52;46.69;United States;Northern America;Mary Ann Liebert Inc.;2011-2021;"Biochemistry (Q2); Drug Discovery (Q2); Molecular Medicine (Q2); Genetics (Q3); Molecular Biology (Q3)"
136;15581;Current Pharmaceutical Biotechnology;journal;13892010, 18734316;0.951;Q1;88;48;166;4332;504;144;2.45;90.25;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Pharmaceutical Science (Q1); Biotechnology (Q2)"
137;25240;Toxicology Letters;journal;03784274, 18793169;0.951;Q2;150;188;724;6858;2276;705;3.06;36.48;Netherlands;Western Europe;Elsevier BV;1977-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
138;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.95;Q2;51;45;124;4719;372;124;3.02;104.87;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
139;25109;Inhalation Toxicology;journal;08958378, 10917691;0.95;Q2;90;146;295;5408;783;290;2.05;37.04;United Kingdom;Western Europe;Informa Healthcare;1989-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q2)"
140;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412703, 19412711;0.946;Q1;73;62;129;1283;352;123;2.63;20.69;United States;Northern America;Mary Ann Liebert Inc.;2008-2021;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q1); Pulmonary and Respiratory Medicine (Q1)"
141;4000148019;AAPS Journal;journal;15507416;0.94;Q1;118;41;220;1724;712;214;3.73;42.05;United States;Northern America;Springer New York;1999-2021;Pharmaceutical Science (Q1)
142;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;0.934;Q2;153;230;634;5435;1798;522;2.63;23.63;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
143;21331;European Journal of Pharmaceutical Sciences;journal;18790720, 09280987;0.933;Q1;144;120;590;3683;1538;584;2.28;30.69;Netherlands;Western Europe;Elsevier;1993-2021;Pharmaceutical Science (Q1)
144;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0.911;Q2;42;18;28;545;50;28;1.79;30.28;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Public Health, Environmental and Occupational Health (Q1); Safety Research (Q1); Toxicology (Q2)"
145;23015;Journal of Ethnopharmacology;journal;03788741, 18727573;0.905;Q2;205;483;1192;17312;3423;1178;2.61;35.84;Ireland;Western Europe;Elsevier Ireland Ltd;1979-2022;"Drug Discovery (Q2); Pharmacology (Q2)"
146;25075;Ecotoxicology;journal;09639292, 15733017;0.899;Q2;97;59;200;3215;395;195;1.99;54.49;Netherlands;Western Europe;Springer Netherlands;1992-2021;"Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
147;16948;Chirality;journal;1520636X, 08990042;0.891;Q2;80;107;321;3836;705;319;2.48;35.85;United States;Northern America;Wiley-Liss Inc.;1989-2021;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
148;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.885;Q2;90;115;247;4155;527;244;1.83;36.13;United States;Northern America;Springer New York;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Computational Theory and Mathematics (Q2); Mathematics (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3)"
149;18075;Neurotoxicology and Teratology;journal;08920362, 18729738;0.884;Q2;103;62;229;3649;622;221;2.66;58.85;United States;Northern America;Elsevier Inc.;1987-2021;"Toxicology (Q2); Developmental Neuroscience (Q3); Cellular and Molecular Neuroscience (Q4)"
150;24786;Alcohol and Alcoholism;journal;07350414, 14643502;0.882;Q2;103;96;302;3591;753;291;2.35;37.41;United Kingdom;Western Europe;Oxford University Press;1965-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q2); Toxicology (Q2)"
151;20473;Life Sciences;journal;18790631, 00243205;0.88;Q1;174;498;1767;20155;4847;1766;2.54;40.47;United States;Northern America;Elsevier Inc.;1962-2021;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2)"
152;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.878;Q2;112;100;246;3961;615;228;2.26;39.61;United States;Northern America;Academic Press Inc.;1970, 1981-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
153;24785;Alcohol;journal;07418329;0.867;Q2;83;55;222;3020;568;214;2.31;54.91;United States;Northern America;Elsevier Inc.;1984-2021;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Neurology (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3)"
154;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.866;Q2;42;32;115;3098;302;108;2.62;96.81;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
155;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.866;Q2;107;255;563;9355;1270;555;2.33;36.69;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q2); Physiology (Q2); Physiology (medical) (Q2)"
156;18966;Mutagenesis;journal;02678357, 14643804;0.866;Q2;95;56;182;2732;484;177;2.67;48.79;United Kingdom;Western Europe;Oxford University Press;1986-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Genetics (Q3); Genetics (clinical) (Q3)"
157;21687;American Journal of PharmacoGenomics;journal;11752203;0.858;Q2;38;0;75;0;226;74;2.97;0;United Kingdom;Western Europe;Adis International Ltd;2001-2005;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
158;16319;IEEE Transactions on Nanobioscience;journal;15361241, 15582639;0.853;Q1;65;48;114;1569;384;109;2.97;32.69;United States;Northern America;Institute of Electrical and Electronics Engineers Inc.;2002-2021;"Computer Science Applications (Q1); Electrical and Electronic Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Nanoscience and Nanotechnology (Q2)"
159;22983;Journal of Clinical Pharmacology;journal;15524604, 00912700;0.848;Q2;121;159;450;4511;1445;441;3.3;28.37;United States;Northern America;Wiley-Blackwell;1973-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
160;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298, 14321912;0.847;Q2;93;78;324;4878;889;315;2.34;62.54;Germany;Western Europe;Springer Verlag;1969-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
161;17464;European Journal of Medicinal Chemistry;journal;02235234, 17683254;0.842;Q2;175;160;444;4962;1130;444;2.4;31.01;France;Western Europe;Elsevier Masson s.r.l.;1974-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
162;21744;Planta Medica;journal;14390221, 00320943;0.839;Q1;122;236;757;5684;1722;747;2;24.08;Germany;Western Europe;Georg Thieme Verlag;1961, 1965-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
163;22432;International Immunopharmacology;journal;18781705, 15675769;0.836;Q2;119;214;610;8640;1534;595;2.36;40.37;Netherlands;Western Europe;Elsevier;2001-2021;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
164;22319;Toxicon;journal;18793150, 00410101;0.828;Q2;133;235;680;9736;1755;665;2.43;41.43;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;Toxicology (Q2)
165;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117, 1533869X;0.824;Q2;38;25;75;1100;163;75;2.2;44;United States;Northern America;Old City Publishing;1996, 2002-2020;"Drug Discovery (Q2); Pharmacology (Q2); Cancer Research (Q3)"
166;20027;BMC Pharmacology;journal;14712210;0.821;Q2;44;18;63;712;153;63;2.13;39.56;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
167;9000153111;Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology;journal;15320456, 18781659;0.82;Q2;113;145;367;8256;927;365;2.58;56.94;United States;Northern America;Elsevier Inc.;1989, 2000-2022;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Physiology (Q2); Toxicology (Q2); Biochemistry (Q3); Cell Biology (Q3)"
168;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.82;Q2;96;114;406;3527;1084;378;2.32;30.94;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
169;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.813;Q2;104;155;743;6594;1541;735;2.31;42.54;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
170;4000150314;Chemical Biology and Drug Design;journal;17470277;0.81;-;82;111;308;3686;564;297;1.81;33.21;United Kingdom;Western Europe;Blackwell;2006-2021;"Biochemistry (Q3); Molecular Medicine (Q3)"
171;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;0.808;Q2;71;65;185;2362;338;158;2.01;36.34;Netherlands;Western Europe;Kluwer Academic Publishers;1987-2021;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
172;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.805;Q2;62;103;231;3089;355;224;1.15;29.99;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1978-2021;"Veterinary (miscellaneous) (Q1); Pharmacology (Q2)"
173;25096;Food and Chemical Toxicology;journal;18736351, 02786915;0.803;Q2;183;376;600;13095;1780;595;2.57;34.83;United Kingdom;Western Europe;Elsevier Ltd.;1982-2021;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2)"
174;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.802;Q2;85;239;796;7047;1325;794;1.67;29.49;United States;Northern America;Wiley-Blackwell;1918-2021;"Drug Discovery (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Biochemistry (Q3); Catalysis (Q3)"
175;22575;Cardiovascular Toxicology;journal;15307905, 15590259;0.801;Q2;56;37;84;1413;205;84;2.02;38.19;United States;Northern America;Humana Press;2001-2021;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
176;20783;Expert Review of Vaccines;journal;14760584, 17448395;0.801;Q2;91;97;263;6944;566;241;2.22;71.59;United Kingdom;Western Europe;Taylor and Francis Ltd.;2002-2021;"Drug Discovery (Q2); Pharmacology (Q2); Immunology (Q3); Molecular Medicine (Q3)"
177;19984;Assay and Drug Development Technologies;journal;1540658X, 15578127;0.796;Q2;58;107;175;1707;354;167;1.85;15.95;United States;Northern America;Mary Ann Liebert Inc.;2002-2021;"Drug Discovery (Q2); Molecular Medicine (Q3)"
178;23942;Biomedical Chromatography;journal;10990801, 02693879;0.788;Q2;68;178;410;3955;767;408;1.81;22.22;United Kingdom;Western Europe;John Wiley and Sons Ltd;1986-2021;"Medicine (miscellaneous) (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
179;20051;BioDrugs;journal;11738804, 1179190X;0.787;Q2;71;46;112;3178;320;110;2.83;69.09;United Kingdom;Western Europe;Adis International Ltd;1997-2021;"Medicine (miscellaneous) (Q1); Biotechnology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
180;20770;Drug Delivery;journal;10717544, 15210464;0.787;Q1;72;66;144;1395;317;144;1.81;21.14;United Kingdom;Western Europe;Informa Healthcare;1993, 1995-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
181;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073, 18755402;0.784;Q2;66;86;250;5158;647;230;2.44;59.98;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1998-2021;"Computer Science Applications (Q1); Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2)"
182;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.783;Q2;58;134;300;3315;973;287;3.94;24.74;Italy;Western Europe;SAGE Publications Inc.;1989-2021;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
183;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;0.779;Q2;104;55;179;2201;452;179;2.26;40.02;Netherlands;Western Europe;Springer Netherlands;1987-2021;"Computer Science Applications (Q2); Drug Discovery (Q2); Physical and Theoretical Chemistry (Q2)"
184;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;0.777;Q2;114;165;481;4259;1213;436;2.46;25.81;Germany;Western Europe;Springer Verlag;1968-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
185;25093;Environmental Toxicology;journal;15227278, 15204081;0.762;Q2;81;74;234;2830;472;230;1.82;38.24;United States;Northern America;"John Wiley &amp; Sons Inc.";1980, 1999-2021;"Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
186;29053;Molecular Diversity;journal;1573501X, 13811991;0.748;Q2;58;19;145;532;293;139;2.1;28;Netherlands;Western Europe;Springer Netherlands;1995-1998, 2000, 2003-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Information Systems (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3); Molecular Biology (Q3)"
187;25151;Journal of Toxicology and Environmental Health - Part A: Current Issues;journal;10872620, 15287394;0.747;Q2;92;230;424;9186;865;417;1.86;39.94;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
188;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.744;Q2;109;107;389;4615;961;376;2.09;43.13;France;Western Europe;Elsevier Masson s.r.l.;1982-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
189;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;0.743;Q2;88;67;120;6384;328;118;2.73;95.28;United Kingdom;Western Europe;Taylor and Francis Ltd.;2005-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
190;16836;BMC Chemical Biology;journal;14726769;0.74;Q2;20;2;8;91;17;8;1.83;45.5;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Drug Discovery (Q2); Molecular Medicine (Q3)"
191;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785, 15578852;0.728;Q2;63;98;237;2813;441;226;1.78;28.7;United States;Northern America;Mary Ann Liebert Inc.;1996-2021;"Medicine (miscellaneous) (Q1); Oncology (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3)"
192;25224;Toxicology in Vitro;journal;18793177, 08872333;0.723;Q2;112;212;405;7274;1083;402;2.64;34.31;United Kingdom;Western Europe;Elsevier Ltd.;1987-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
193;17067;Phytomedicine;journal;09447113, 1618095X;0.721;Q1;127;145;343;3506;798;329;2.18;24.18;Germany;Western Europe;Urban und Fischer Verlag Jena;1994-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
194;16533;Phytochemical Analysis;journal;09580344, 10991565;0.719;Q2;76;67;201;1402;343;201;1.54;20.93;United Kingdom;Western Europe;John Wiley and Sons Ltd;1990-2021;"Complementary and Alternative Medicine (Q1); Food Science (Q1); Medicine (miscellaneous) (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Plant Science (Q2); Biochemistry (Q3); Molecular Medicine (Q3)"
195;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.718;Q1;122;467;1414;13438;2810;1408;1.88;28.78;Japan;Asiatic Region;Pharmaceutical Society of Japan;1993-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
196;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.716;Q2;40;35;100;3696;231;100;2.15;105.6;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Pharmacology (Q2)"
197;25214;Toxicologic Pathology;journal;15331601, 01926233;0.716;Q2;112;123;310;5192;790;299;2.42;42.21;United States;Northern America;SAGE Publications Inc.;1972-2021;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
198;21353;Expert Opinion on Therapeutic Patents;journal;13543776, 17447674;0.714;Q2;77;113;354;6110;508;343;1.43;54.07;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
199;20129;Cardiovascular Drug Reviews;journal;15273466, 08975957;0.713;Q2;50;25;70;1751;182;69;2.27;70.04;United States;Northern America;Neva Press, Inc.;1983-2007;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
200;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.712;Q2;87;149;415;6825;717;408;1.69;45.81;Canada;Northern America;National Research Council of Canada;1964-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q3); Physiology (medical) (Q3)"
201;16803;Antiviral Chemistry and Chemotherapy;journal;20402066, 09563202;0.711;Q2;54;32;99;1372;200;97;1.76;42.88;United Kingdom;Western Europe;SAGE Publications Inc.;1991-2015, 2017-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2); Virology (Q3)"
202;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;0.709;Q1;133;39;84;1298;252;74;3;33.28;United States;Northern America;Elsevier Inc.;2005-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Materials Science (miscellaneous) (Q2); Molecular Medicine (Q3); Nanoscience and Nanotechnology (Q3)"
203;15840;Journal of Antibiotics;journal;00218820, 18811469;0.701;Q2;84;96;326;2009;471;311;1.26;20.93;United Kingdom;Western Europe;Japan Antibiotics Research Association;1953-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
204;24578;Mathematical Medicine and Biology;journal;14778599;0.701;Q2;46;20;55;637;94;54;1.5;31.85;United Kingdom;Western Europe;Oxford University Press;1984-2021;"Environmental Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Applied Mathematics (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Modeling and Simulation (Q2); Pharmacology (Q2); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3)"
205;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.697;Q2;75;82;186;2655;447;175;2.37;32.38;United States;Northern America;Elsevier Inc.;1992-2002, 2004-2021;"Pharmacology (Q2); Toxicology (Q2)"
206;14805;Steroids;journal;0039128X, 18785867;0.696;Q2;107;109;363;4174;890;362;2.31;38.29;United States;Northern America;Elsevier Inc.;1963-2021;"Clinical Biochemistry (Q2); Endocrinology (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
207;22318;Toxicological Reviews;journal;11762551;0.689;Q2;46;0;72;0;205;65;2.53;0;United Kingdom;Western Europe;Adis International Ltd;2003-2006;"Pharmacology (Q2); Toxicology (Q2)"
208;20026;BMC Clinical Pharmacology;journal;14726904;0.682;Q2;39;14;20;370;60;20;3.14;26.43;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
209;23412;Journal of AOAC International;journal;10603271;0.682;Q2;90;205;655;4894;1159;641;1.71;23.87;United States;Northern America;AOAC International;1993-2021;"Agronomy and Crop Science (Q1); Food Science (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Pharmacology (Q2)"
210;24604;Archives of Toxicology;journal;14320738, 03405761;0.681;Q2;121;98;286;3621;610;283;1.95;36.95;Germany;Western Europe;Springer Verlag;1930-1940, 1943-1944, 1972-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
211;21865;Fundamental and Clinical Pharmacology;journal;07673981, 14728206;0.679;Q2;77;91;218;3491;509;215;2.56;38.36;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1987-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
212;144956;Drug Metabolism and Pharmacokinetics;journal;13474367;0.674;Q1;69;60;173;406;454;173;2.53;6.77;Japan;Asiatic Region;Japanese Society for the Study of Xenobiotics;2002-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
213;130063;Pharmacological Reports;journal;17341140;0.673;Q2;87;123;364;4619;752;363;2.28;37.55;Netherlands;Western Europe;Elsevier BV;2005-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
214;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0.67;Q2;98;252;700;9513;1313;695;1.78;37.75;United Kingdom;Western Europe;Nature Publishing Group;1980-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
215;19900192900;Molecular Informatics;journal;18681751, 18681743;0.664;Q2;70;95;263;3918;584;251;2.1;41.24;Germany;Western Europe;"Wiley - VCH Verlag GmbH &amp; CO. KGaA";2010-2021;"Computer Science Applications (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3); Structural Biology (Q3)"
216;29682;Receptors and Channels;journal;10606823;0.663;Q2;42;0;19;0;50;19;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2004;"Clinical Biochemistry (Q2); Pharmacology (Q2); Cell Biology (Q3); Endocrinology (Q3)"
217;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427843, 17427835;0.662;Q2;93;133;411;4568;893;398;2.12;34.35;United States;Northern America;Wiley-Blackwell;2004-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
218;21229;Drug News and Perspectives;journal;02140934;0.656;Q2;51;78;244;3455;417;243;1.68;44.29;Spain;Western Europe;Prous Science;1990-2010;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
219;24028;Reproductive Toxicology;journal;08906238, 18731708;0.656;Q2;117;114;341;5920;796;312;2.2;51.93;United States;Northern America;Elsevier Inc.;1987-2021;Toxicology (Q2)
220;20570;Chemotherapy;journal;00093157, 14219794;0.648;Q2;58;84;208;2353;378;203;1.82;28.01;Switzerland;Western Europe;S. Karger AG;1960-2021;"Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
221;4400151608;ChemMedChem;journal;18607187, 18607179;0.638;Q1;106;174;412;9148;822;410;2.14;52.57;United Kingdom;Western Europe;John Wiley and Sons Ltd;2006-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Organic Chemistry (Q2); Molecular Medicine (Q3)"
222;20634;Journal of Texture Studies;journal;00224901, 17454603;0.636;Q2;57;41;117;1304;151;113;1.21;31.8;United States;Northern America;Wiley-Blackwell;1969-2021;"Food Science (Q1); Pharmaceutical Science (Q2)"
223;23039;Journal of Liposome Research;journal;08982104, 15322394;0.634;Q2;53;24;63;759;137;61;2.27;31.63;United Kingdom;Western Europe;Informa Healthcare;1988-1990, 1992-2021;Pharmaceutical Science (Q2)
224;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.627;Q2;81;62;214;1569;289;212;1.31;25.31;United Kingdom;Western Europe;Informa Healthcare;1984-2021;"Bioengineering (Q2); Colloid and Surface Chemistry (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Physical and Theoretical Chemistry (Q2)"
225;21100370879;"Journal of managed care &amp; specialty pharmacy";journal;23761032, 23760540;0.62;Q2;66;125;296;3163;341;205;1.17;25.3;United States;Northern America;Academy of Managed Care Pharmacy (AMCP);2014-2021;"Pharmacy (Q1); Health Policy (Q2); Pharmaceutical Science (Q2)"
226;22410;Inflammation Research;journal;1420908X, 10233830;0.618;Q2;94;120;409;3353;641;403;1.65;27.94;Switzerland;Western Europe;Birkhauser Verlag Basel;1995-2021;"Pharmacology (Q2); Immunology (Q3)"
227;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.617;Q2;74;71;207;2500;406;206;1.39;35.21;United States;Northern America;Wiley-Blackwell;1986-2021;"Applied Microbiology and Biotechnology (Q2); Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Process Chemistry and Technology (Q2); Molecular Medicine (Q3)"
228;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.616;Q2;90;143;339;3813;483;336;1.22;26.66;United States;Northern America;Informa Healthcare;1974, 1976-2021;"Drug Discovery (Q2); Pharmacology (Q2); Organic Chemistry (Q3)"
229;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.61;Q2;63;96;263;3410;499;242;1.89;35.52;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1960-1961, 1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
230;4000148406;Clinical Toxicology;journal;15569519, 15563650;0.609;Q2;98;142;278;3549;526;230;1.64;24.99;United Kingdom;Western Europe;Informa Healthcare;1968-1998, 2005-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
231;25898;Journal of Peptide Science;journal;10752617, 10991387;0.609;Q2;68;107;284;3791;499;275;1.75;35.43;United Kingdom;Western Europe;John Wiley and Sons Ltd;1995-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Structural Biology (Q3); Molecular Biology (Q4)"
232;19374;AAPS PharmSciTech;journal;15309932;0.606;Q2;101;119;255;2963;447;243;1.73;24.9;Switzerland;Western Europe;Springer International Publishing AG;2000-2021;"Agronomy and Crop Science (Q2); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
233;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.605;Q2;62;68;152;2034;195;149;1.06;29.91;United States;Northern America;Informa Healthcare;1996-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
234;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.6;Q2;81;187;441;5978;787;437;1.68;31.97;Poland;Eastern Europe;Polish Physiological Society;1991-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
235;25864;Heterocycles;journal;03855414;0.599;Q2;66;424;1082;12637;1253;1078;1.13;29.8;Japan;Asiatic Region;Japan Institute of Heterocyclic Chemistry;1983-2021;"Analytical Chemistry (Q2); Pharmacology (Q2); Organic Chemistry (Q3)"
236;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.599;Q2;91;77;214;3151;480;206;2.2;40.92;United Kingdom;Western Europe;John Wiley and Sons Ltd;1981-2021;Toxicology (Q2)
237;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.593;Q2;64;40;91;1301;169;87;1.9;32.53;United States;Northern America;Springer New York;1996-1999, 2001-2021;Pharmacology (Q2)
238;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.589;Q3;62;49;137;1705;244;137;1.71;34.8;United States;Northern America;"John Wiley &amp; Sons Inc.";1998-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Molecular Medicine (Q3); Toxicology (Q3); Molecular Biology (Q4)"
239;4400151410;Human Vaccines;journal;15548600, 15548619;0.588;Q1;58;56;81;1667;138;78;1.7;29.77;United States;Northern America;Landes Bioscience;2005-2011;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Immunology (Q3)"
240;23102;Journal of Pharmacy and Pharmacology;journal;20427158, 00223573;0.587;Q2;124;207;620;8386;1184;615;1.87;40.51;United Kingdom;Western Europe;Oxford University Press;1949-2021;"Pharmaceutical Science (Q2); Pharmacology (Q2)"
241;16067;Reading Teacher;journal;00340561;0.581;Q2;53;83;217;1799;99;216;0.35;21.67;United States;Northern America;Wiley-Blackwell;1995-2021;"Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
242;16573;Phytotherapy Research;journal;10991573, 0951418X;0.578;Q2;140;231;625;6542;1215;622;1.79;28.32;United Kingdom;Western Europe;John Wiley and Sons Ltd;1987-2021;Pharmacology (Q2)
243;21352;Expert Opinion on Pharmacotherapy;journal;17447666, 14656566;0.577;Q2;83;274;698;20007;1505;685;2.18;73.02;United Kingdom;Western Europe;Taylor and Francis Ltd.;1999-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
244;4700152603;Medicinal Chemistry;journal;15734064, 18756638;0.576;Q2;46;73;133;2773;213;133;1.6;37.99;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;Drug Discovery (Q2)
245;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.576;Q2;78;35;135;1124;300;128;2.06;32.11;Switzerland;Western Europe;S. Karger AG;1988-1997, 2004-2021;"Dermatology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
246;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.575;Q2;81;63;149;2206;341;148;1.95;35.02;Canada;Northern America;Canadian Society for Pharmaceutical Sciences;1998-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q2)"
247;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.574;Q3;64;43;92;1909;171;92;1.9;44.4;Netherlands;Western Europe;Springer Netherlands;1984-2021;"Health, Toxicology and Mutagenesis (Q2); Cell Biology (Q3); Toxicology (Q3)"
248;130047;Current Drug Discovery Technologies;journal;15701638;0.557;Q2;44;27;68;1603;133;67;1.5;59.37;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Drug Discovery (Q2)
249;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.555;Q2;52;85;206;1538;201;189;0.74;18.09;United States;Northern America;Taylor and Francis Ltd.;1991-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q3)"
250;14822;Xenobiotica;journal;00498254, 13665928;0.555;Q2;82;89;221;3686;444;220;2.01;41.42;United Kingdom;Western Europe;Informa Healthcare;1971-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Biochemistry (Q3); Toxicology (Q3)"
251;21207;Drug Discovery Today: Technologies;journal;17406749;0.553;Q2;53;21;176;331;302;166;1.25;15.76;United Kingdom;Western Europe;Elsevier Ltd.;2004-2021;"Drug Discovery (Q2); Biotechnology (Q3); Molecular Medicine (Q3)"
252;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.546;Q2;95;346;1064;8121;1496;1064;1.32;23.47;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-2021;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
253;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.544;Q2;76;81;245;2515;393;228;1.53;31.05;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1976-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
254;21256;Drugs of Today;journal;00257656, 16993993, 16994019;0.541;Q3;53;72;247;4811;517;244;2.17;66.82;Spain;Western Europe;Prous Science;1968, 1978-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
255;18077;Fitoterapia;journal;0367326X, 18736971;0.54;Q2;110;148;430;2263;715;429;1.41;15.29;Netherlands;Western Europe;Elsevier;1948-1949, 1961, 1972-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
256;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.534;Q3;79;96;259;2838;437;256;1.48;29.56;United Kingdom;Western Europe;Informa Healthcare;1985-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
257;19443;American Journal of Health-System Pharmacy;journal;10792082, 15352900;0.526;Q3;99;480;1232;7777;1407;769;1.11;16.2;United States;Northern America;American Society of Health-Systems Pharmacy;1995-2021;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
258;14487;Journal of Ocular Pharmacology and Therapeutics;journal;15577732, 10807683;0.518;Q3;64;76;180;2222;260;177;1.44;29.24;United States;Northern America;Mary Ann Liebert Inc.;1987, 1991-1993, 1995-2021;"Ophthalmology (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
259;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.513;Q3;50;47;112;1882;219;112;1.77;40.04;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2021;"Medicine (miscellaneous) (Q2); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
260;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.504;Q3;67;112;340;1330;326;304;0.89;11.88;United States;Northern America;American Pharmacists Association;2003-2021;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q3)"
261;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.503;Q3;69;89;300;2065;469;284;1.31;23.2;Germany;Western Europe;Dustri-Verlag Dr. Karl Feistle;1994-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
262;144790;Marine Drugs;journal;16603397;0.501;Q3;128;17;49;670;76;48;1.13;39.41;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2003-2021;Drug Discovery (Q3)
263;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.499;Q3;52;40;96;2243;159;93;1.64;56.08;United States;Northern America;Wiley-Liss Inc.;2003-2016;"Embryology (Q2); Developmental Biology (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
264;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;0.499;Q3;46;22;27;2750;35;27;1.3;125;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3); Drug Discovery (Q3); Oncology (Q3)"
265;21124;Pharmaceutical Statistics;journal;15391612, 15391604;0.493;Q3;39;27;97;609;58;81;0.6;22.56;United Kingdom;Western Europe;John Wiley and Sons Ltd;2004-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3); Statistics and Probability (Q3)"
266;14990;Current Neuropharmacology;journal;18756190, 1570159X;0.489;Q3;82;27;83;3824;86;79;0.94;141.63;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2); Neurology (Q3); Neurology (clinical) (Q3); Pharmacology (Q3)"
267;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.483;Q2;65;76;228;2112;302;225;1.31;27.79;Germany;Western Europe;Wiley-VCH Verlag;1822-1831, 1835-1933, 1937-1938, 1940, 1943-1944, 1950-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
268;110172;Progress in Drug Research;book series;0071786X;0.481;Q1;44;13;23;993;33;21;1.43;76.38;Switzerland;Western Europe;Birkhauser Verlag Basel;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
269;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.479;Q3;48;246;311;4597;339;310;1.08;18.69;United Kingdom;Western Europe;John Wiley and Sons Ltd;1976-2021;"Radiology, Nuclear Medicine and Imaging (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Spectroscopy (Q3)"
270;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.474;Q2;51;208;648;5419;642;644;1.04;26.05;United States;Northern America;Taylor and Francis Ltd.;1996-2021;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Clinical Biochemistry (Q3)"
271;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X, 1414431X;0.473;Q1;91;201;655;6101;979;653;1.44;30.35;Brazil;Latin America;Associacao Brasileira de Divulgacao Cientifica;1973-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3); Cell Biology (Q4)"
272;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.468;Q2;61;57;149;1435;207;149;1.29;25.18;United Kingdom;Western Europe;John Wiley and Sons Ltd;1979-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
273;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.466;Q3;88;101;352;3622;492;349;1.43;35.86;Netherlands;Western Europe;Elsevier;1996-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
274;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.461;Q3;47;31;101;1086;195;99;1.89;35.03;United States;Northern America;Begell House Inc.;1984-1990, 1992-2021;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
275;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.457;Q3;24;24;75;2422;83;69;0.92;100.92;United Arab Emirates;Middle East;Bentham Science Publishers;2012-2021;"Infectious Diseases (Q3); Pharmacology (Q3)"
276;18800156720;Dissolution Technologies;journal;1521298X;0.457;Q2;34;22;75;222;32;31;0.39;10.09;United States;Northern America;Dissolution Technologies Inc;1996-2021;Pharmaceutical Science (Q2)
277;20580;Journal of Food Biochemistry;journal;17454514, 01458884;0.457;Q3;50;51;125;1785;126;124;1.01;35;United States;Northern America;Wiley-Blackwell;1977-2021;"Food Science (Q2); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
278;13248;Experimental and Toxicologic Pathology;journal;09402993, 16181433;0.453;Q3;70;61;168;1906;288;167;1.66;31.25;Germany;Western Europe;Urban und Fischer Verlag Jena;1992-2017;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Toxicology (Q3); Cell Biology (Q4)"
279;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.453;Q3;38;57;72;2253;76;70;1.06;39.53;Netherlands;Western Europe;Springer Netherlands;1996-2002, 2005-2021;"Analytical Chemistry (Q3); Biochemistry (Q3); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
280;4700152848;PPAR Research;journal;16874757, 16874765;0.45;Q3;52;40;12;2800;14;10;1.17;70;United States;Northern America;Hindawi Publishing Corporation;2006-2021;"Pharmacology (medical) (Q2); Drug Discovery (Q3)"
281;4700152426;Current Pharmaceutical Analysis;journal;15734129;0.435;Q2;25;28;32;2492;32;32;1;89;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmaceutical Science (Q2); Biochemistry (Q3); Biophysics (Q3); Molecular Medicine (Q3)"
282;21273;Journal of Immune Based Therapies and Vaccines;journal;14768518;0.435;Q3;21;11;23;364;29;23;0.79;33.09;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2011;"Immunology (Q3); Pharmacology (Q3)"
283;27210;In Vivo;journal;17917549, 0258851X;0.432;Q3;64;164;420;5307;584;418;1.33;32.36;Greece;Western Europe;International Institute of Anticancer Research;1987-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
284;21211;Pharmacy Education;journal;14772701, 15602214;0.426;Q2;18;48;98;805;61;97;0.49;16.77;Netherlands;Western Europe;;1973-1978, 2002-2021;"Pharmacy (Q1); Education (Q2); Pharmaceutical Science (Q2)"
285;29947;Journal of Chemotherapy;journal;1120009X, 19739478;0.419;Q3;52;143;456;3234;532;421;1.05;22.62;United Kingdom;Western Europe;Maney Publishing;1989-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
286;25106;Human and Experimental Toxicology;journal;09603271;0.408;Q3;82;122;263;4491;424;249;1.42;36.81;United States;Northern America;SAGE Publications Inc.;1981-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
287;21194;Pharmacology;journal;00317012, 14230313;0.406;Q3;60;73;246;2902;334;246;1.26;39.75;Switzerland;Western Europe;S. Karger AG;1959-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
288;19398;Acta Pharmaceutica;journal;18469558, 13300075;0.404;Q2;60;40;113;988;178;111;1.42;24.7;Croatia;Eastern Europe;Croatian Pharmaceutical Society;1986, 1992-2022;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
289;13671;Biologicals;journal;10958320, 10451056;0.404;Q3;60;54;124;1341;161;114;1.14;24.83;United States;Northern America;Academic Press Inc.;1990-2021;"Medicine (miscellaneous) (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biotechnology (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Pharmacology (Q3)"
290;26370;Molecules;journal;14203049;0.404;Q2;171;226;378;7258;384;364;0.85;32.12;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);1992, 1996-2021;"Chemistry (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
291;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;0.398;Q3;34;22;25;2775;29;25;1.16;126.14;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2016;"Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2); Drug Discovery (Q3)"
292;4200151509;Molecular Diagnosis and Therapy;journal;11771062;0.396;Q3;47;42;43;2187;78;41;1.81;52.07;United Kingdom;Western Europe;Adis International Ltd;2001, 2004, 2006-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Genetics (Q4); Molecular Medicine (Q4)"
293;19958;Archives of Pharmacal Research;journal;19763786, 02536269;0.395;Q3;93;239;617;6233;728;617;1.15;26.08;South Korea;Asiatic Region;Pharmaceutical Society of Korea;1978-2021;"Drug Discovery (Q3); Organic Chemistry (Q3); Molecular Medicine (Q4)"
294;5800173383;Current Clinical Pharmacology;journal;15748847, 22123938;0.389;Q1;0;0;0;0;0;0;0;0;United Arab Emirates;Middle East;Bentham Science Publishers;2006-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
295;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.387;Q3;53;57;119;1481;150;119;1.27;25.98;Japan;Asiatic Region;Japanese Society of Toxicological Sciences;1976-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
296;22411;Inflammopharmacology;journal;09254692, 15685608;0.385;Q3;55;53;128;1647;143;122;1.2;31.08;Switzerland;Western Europe;Birkhauser Verlag Basel;1991-2021;"Pharmacology (medical) (Q2); Immunology (Q3); Pharmacology (Q3)"
297;21264;Drugs in R and D;journal;11796901, 11745886;0.381;Q3;47;41;152;1804;208;152;1.64;44;United Kingdom;Western Europe;Adis International Ltd;1999, 2002-2008, 2010-2021;Pharmacology (Q3)
298;22204;Journal of Drug Delivery Science and Technology;journal;17732247, 25888943;0.38;Q2;52;65;204;1957;155;204;0.75;30.11;France;Western Europe;Editions de Sante;2004-2021;Pharmaceutical Science (Q2)
299;21262;Drugs under Experimental and Clinical Research;journal;03786501;0.379;Q3;39;0;66;0;111;66;1.47;0;Switzerland;Western Europe;Bioscience Ediprint Inc.;1980-2005;"Pharmacology (medical) (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
300;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.375;Q3;61;87;345;2446;392;315;1.86;28.11;United Kingdom;Western Europe;FRAME;1982, 1985-1986, 1988-1989, 1994-2021;"Medical Laboratory Technology (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q3)"
301;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.373;Q2;63;77;226;1722;231;203;0.9;22.36;Netherlands;Western Europe;Springer Netherlands;2011-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3); Toxicology (Q3)"
302;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.367;Q3;46;31;102;1097;138;102;1.26;35.39;United States;Northern America;Informa Healthcare;1977-2021;"Chemical Health and Safety (Q1); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
303;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;0.366;Q3;29;42;215;1785;176;204;0.67;42.5;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
304;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.366;Q2;23;10;38;293;52;38;1.42;29.3;United Kingdom;Western Europe;BioMed Central Ltd.;2002-2017;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
305;21192;Drug Development Research;journal;02724391, 10982299;0.361;Q3;62;59;261;3381;280;254;1.09;57.31;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;Drug Discovery (Q3)
306;19441;American Journal of Drug Delivery;journal;11759038;0.358;Q3;22;0;69;0;67;63;0.84;0;United Kingdom;Western Europe;Adis International Ltd;2004-2006;Pharmacology (Q3)
307;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.357;Q3;76;249;935;4597;610;933;0.58;18.46;United States;Northern America;Springer New York;1966-2021;"Medicine (miscellaneous) (Q2); Pollution (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
308;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.346;Q3;36;25;58;627;63;58;1.23;25.08;Germany;Western Europe;Walter de Gruyter GmbH;1985-1988, 1990-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3); Physiology (Q4)"
309;23009;Journal of Clinical Research;journal;13695207;0.345;Q3;11;1;7;16;13;7;1.17;16;United Kingdom;Western Europe;PJB Publications Ltd.;1998-2009;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
310;15340;Developments in Biologicals;journal;14246074, 16622960;0.343;Q3;38;91;342;1176;313;342;1.05;12.92;Switzerland;Western Europe;S. Karger AG;2000-2008, 2010, 2012-2013;"Immunology (Q3); Pharmacology (Q3); Biomaterials (Q4)"
311;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;0.342;Q3;10;0;49;0;16;28;0.18;0;United States;Northern America;Academic Press Inc.;2004-2005, 2008, 2012-2017, 2019;"Drug Discovery (Q3); Organic Chemistry (Q3)"
312;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.341;Q3;62;72;190;3810;227;175;1.23;52.92;United States;Northern America;SAGE Publications Inc.;1982-2021;Toxicology (Q3)
313;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.34;Q2;57;48;125;1195;137;123;1.21;24.9;United States;Northern America;Informa Healthcare;2013-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3)"
314;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.34;Q3;53;46;162;1412;170;160;1.07;30.7;United Kingdom;Western Europe;Informa Healthcare;1978-2021;"Medicine (miscellaneous) (Q2); Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3)"
315;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0.336;Q3;53;75;215;4091;247;214;1.04;54.55;Spain;Western Europe;Prous Science;1979-2010;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
316;21717;Die Pharmazie;journal;00317144;0.335;Q2;66;199;670;4457;638;667;0.94;22.4;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-2021;Pharmaceutical Science (Q2)
317;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.33;Q3;64;32;182;974;131;167;0.32;30.44;United States;Northern America;Heldref Publications;2005-2021;"Environmental Science (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
318;20545;PDA Journal of Pharmaceutical Science and Technology;journal;19482124, 10797440;0.325;Q2;40;51;117;921;78;100;0.71;18.06;United States;Northern America;Parenteral Drug Association Inc.;1994-2021;Pharmaceutical Science (Q2)
319;19427;Advances in Pharmacology;journal;15578925, 10543589;0.32;Q3;78;14;96;2270;63;89;0.74;162.14;United States;Northern America;Academic Press Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
320;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.317;Q2;42;114;252;1350;169;252;0.64;11.84;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4); Organic Chemistry (Q4)"
321;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.317;Q3;51;155;335;4166;204;334;0.6;26.88;India;Asiatic Region;Triveni Enterprises;1988-2021;"Environmental Engineering (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
322;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;0.313;Q3;77;46;40;2128;32;38;0.8;46.26;United States;Northern America;Springer New York;2006-2021;"Immunology (Q3); Immunology and Allergy (Q3); Neuroscience (miscellaneous) (Q3); Pharmacology (Q3)"
323;59665;Chinese Journal of Natural Medicines;journal;16723651;0.303;Q3;40;103;278;1483;139;277;0.4;14.4;China;Asiatic Region;China Pharmaceutical University;2004-2021;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Drug Discovery (Q3)"
324;22881;Yaoxue Xuebao;journal;05134870;0.303;Q2;34;243;693;3896;420;693;0.61;16.03;China;Asiatic Region;Chinese Pharmaceutical Association;1960, 1962-1966, 1979-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Molecular Medicine (Q4)"
325;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699, 09750983;0.3;Q2;48;183;808;4144;369;807;0.39;22.64;India;Asiatic Region;Scientific Publishers of India;1970, 1973-1978, 1981, 1989-1991, 1996-2018, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q4)"
326;25144;Journal of Health Science;journal;13475207, 13449702;0.298;Q3;49;117;343;2876;238;343;0.73;24.58;Japan;Asiatic Region;Pharmaceutical Society of Japan;1999-2011;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
327;23489;Chemical Speciation and Bioavailability;journal;09542299;0.296;Q3;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1989-2018;"Chemical Health and Safety (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
328;20083;British Journal of Clinical Pharmacology, Supplement;journal;02643774;0.294;Q2;32;0;7;0;20;7;0;0;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1998, 2000-2004;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
329;19446;American Pharmaceutical Review;journal;10998012;0.29;Q2;24;116;291;1850;164;279;0.59;15.95;United States;Northern America;Russell Publishing LLC;2002-2020;Pharmaceutical Science (Q2)
330;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;0.289;Q3;68;132;65;10317;63;65;0.97;78.16;United Kingdom;Western Europe;Informa Healthcare;2006-2021;Drug Discovery (Q3)
331;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.287;Q2;61;212;559;3559;241;557;0.41;16.79;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-2021;Pharmaceutical Science (Q2)
332;22435;International Journal of Clinical Pharmacology Research;journal;02511649;0.284;Q2;31;0;42;0;58;42;1.4;0;Switzerland;Western Europe;Bioscience Ediprint Inc.;1981-2005;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
333;22456;International Journal of Pharmacy Practice;journal;09617671, 20427174;0.284;Q2;39;51;111;1226;64;105;0.6;24.04;United Kingdom;Western Europe;Oxford University Press;1991-2021;"Pharmacy (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Health Policy (Q3); Public Health, Environmental and Occupational Health (Q3)"
334;22375;Indian Drugs;journal;0019462X;0.283;Q2;31;180;414;2741;118;414;0.24;15.23;India;Asiatic Region;Indian Drug Manufacturers' Association;1989-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
335;7700153108;International Journal of Nanomedicine;journal;11782013, 11769114;0.282;Q3;145;47;59;2505;41;55;0.69;53.3;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Medicine (miscellaneous) (Q2); Bioengineering (Q3); Biophysics (Q3); Drug Discovery (Q3); Biomaterials (Q4); Nanoscience and Nanotechnology (Q4); Organic Chemistry (Q4)"
336;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.282;Q3;62;55;96;2542;109;96;1.09;46.22;United Kingdom;Western Europe;SAGE Publications Ltd;1985-2021;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
337;21100470510;Drug Research;journal;21949379, 21949387;0.281;Q3;65;141;385;2709;311;382;0.8;19.21;Germany;Western Europe;Thieme;1972, 2013-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3)"
338;73430;Pharmaceutical Technology;journal;15432521;0.281;Q2;38;191;567;753;136;381;0.22;3.94;United States;Northern America;Advanstar Communications Inc.;1979-1985, 1987, 1996-2021;"Pharmaceutical Science (Q2); Biophysics (Q3)"
339;21265;Drugs of the Future;journal;03778282;0.278;Q3;45;120;1347;6411;257;356;0.23;53.43;Spain;Western Europe;Prous Science;1978-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
340;20578;Journal of Food and Drug Analysis;journal;10219498;0.272;Q3;63;64;174;1970;106;174;0.59;30.78;Taiwan;Asiatic Region;National Laboratories of Foods and Drugs;1994-2021;"Food Science (Q3); Pharmacology (Q3)"
341;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.268;Q2;69;131;359;1806;204;344;0.54;13.79;United States;Northern America;American Association of Colleges of Pharmacy;1945-1948, 1973-1989, 1991, 1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Education (Q3)"
342;37697;Autonomic and Autacoid Pharmacology;journal;14748673, 14748665;0.266;Q3;21;24;102;824;67;101;0.61;34.33;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2002-2017;Pharmacology (Q3)
343;25253;Blutalkohol (discontinued);journal;00065250;0.266;Q3;13;23;101;381;23;92;0.21;16.57;Germany;Western Europe;Steintor-Verlag GmbH;1974-2017, 2020-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
344;63982;Journal of Cannabis Therapeutics;journal;15299775, 15299783;0.265;Q3;16;0;4;0;6;3;0;0;United States;Northern America;Haworth Integrative Healing Press;2001-2004;Pharmacology (Q3)
345;130038;Letters in Drug Design and Discovery;journal;15701808;0.261;Q2;35;99;213;3076;127;213;0.6;31.07;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
346;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;0.257;Q3;27;42;220;2084;110;203;0.42;49.62;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q3); Molecular Medicine (Q4)"
347;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.256;Q3;33;22;75;633;32;75;0.43;28.77;United States;Northern America;Begell House Inc.;2005-2021;"Applied Microbiology and Biotechnology (Q3); Drug Discovery (Q3); Pharmacology (Q3)"
348;62892;Drug Discovery Today: BIOSILICO;journal;17418364;0.255;Q3;17;0;45;0;42;35;0;0;Netherlands;Western Europe;Elsevier BV;2003-2004;Drug Discovery (Q3)
349;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;21070180, 03787966;0.247;Q3;39;28;111;500;59;105;0.53;17.86;France;Western Europe;Springer Paris;1976-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
350;17700155034;Natural Product Communications;journal;15559475, 1934578X;0.247;Q3;50;172;167;4091;72;161;0.43;23.78;United States;Northern America;SAGE Publications Inc.;2006-2022;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Plant Science (Q3)"
351;4700152607;Current Enzyme Inhibition;journal;15734080;0.245;Q3;18;25;29;3343;22;29;0.76;133.72;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery (Q3); Biochemistry (Q4); Molecular Medicine (Q4)"
352;5800228222;Journal of Pharmaceutical Innovation;journal;18725120, 19398042;0.241;Q2;31;16;10;226;11;8;1.1;14.13;United States;Northern America;Springer New York;2006-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
353;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.24;Q3;46;56;163;2292;133;162;0.87;40.93;United Kingdom;Western Europe;Informa Healthcare;1991-2021;"Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
354;130089;Toxin Reviews;journal;15569543, 15569551;0.239;Q3;46;16;76;1078;59;71;0.62;67.38;United Kingdom;Western Europe;Informa Healthcare;1982-2021;Toxicology (Q3)
355;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.234;Q3;40;34;71;1393;50;70;0.63;40.97;United States;Northern America;Informa Healthcare;2004-2021;"Toxicology (Q3); Immunology (Q4)"
356;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X, 22124071;0.234;Q3;0;0;0;0;0;0;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2020;"Drug Discovery (Q3); Infectious Diseases (Q3); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
357;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.234;Q4;41;0;74;0;35;25;0.47;0;Netherlands;Western Europe;Elsevier;1995-1997, 2000-2003, 2005-2006, 2008, 2012-2021;"Drug Discovery (Q4); Organic Chemistry (Q4)"
358;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.233;Q3;62;74;351;1560;177;235;0.5;21.08;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-1980, 1982, 1984-1986, 1994-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
359;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.232;Q2;46;14;57;251;20;57;0.26;17.93;Switzerland;Western Europe;MDPI AG;1949, 1960-1961, 1973-2021;Pharmaceutical Science (Q2)
360;20065;BioPharm International;trade journal;1542166X, 19391862;0.231;Q2;29;142;406;945;81;348;0.19;6.65;United States;Northern America;Advanstar Communications Inc.;2002-2020;"Pharmaceutical Science (Q2); Biotechnology (Q3)"
361;26767;Altex;journal;1868596X, 18688551;0.23;Q3;57;73;83;590;58;80;0.67;8.08;Germany;Western Europe;Springer International Publishing AG;2000-2021;"Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
362;24097;Journal of the Indian Chemical Society;journal;00194522;0.23;Q4;33;245;792;5100;288;781;0.3;20.82;India;Asiatic Region;Elsevier BV;1973-1985, 1987-1991, 1996-2021;"Drug Discovery (Q4); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
363;20599;Paediatric and Perinatal Drug Therapy;journal;14630095;0.23;Q3;19;21;56;477;36;47;0.65;22.71;United Kingdom;Western Europe;Librapharm;1997-2008;"Pediatrics, Perinatology and Child Health (Q3); Pharmacology (Q3)"
364;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;0.228;Q4;12;30;98;715;38;97;0.4;23.83;Japan;Asiatic Region;Medical and Pharmaceutical Society for WAKAN-YAKU;2004-2013;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q4)"
365;22906;Journal of China Pharmaceutical University;journal;10005048;0.227;Q2;14;131;413;1482;131;413;0.29;11.31;China;Asiatic Region;China Pharmaceutical University;1989-1991, 2002-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
366;94084;Drug Discovery Today: TARGETS;journal;17418372;0.226;Q4;15;0;64;0;33;54;0;0;Netherlands;Western Europe;Elsevier BV;2002-2004;Drug Discovery (Q4)
367;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.226;Q3;72;130;383;3668;213;381;0.45;28.22;United Kingdom;Western Europe;Taylor and Francis Ltd.;1961-1972, 1975-2021;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
368;22908;Chinese Pharmacological Bulletin;journal;10011978;0.224;Q3;17;384;1120;5428;570;1120;0.57;14.14;China;Asiatic Region;Institute of Clinical Pharmacology;1993-2020;Pharmacology (Q3)
369;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.224;Q3;66;42;105;1487;86;104;0.66;35.4;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1979-2021;"Aging (Q3); Chemistry (miscellaneous) (Q3); Colloid and Surface Chemistry (Q3); Dermatology (Q3); Pharmaceutical Science (Q3); Drug Discovery (Q4)"
370;22357;IDrugs : the investigational drugs journal;journal;13697056, 20403410;0.221;Q3;35;175;588;836;237;583;0.42;4.78;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
371;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.22;Q2;36;13;41;436;23;41;0.18;33.54;Germany;Western Europe;Walter de Gruyter GmbH;2015-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
372;4700151615;Scandinavian Journal of Work, Environment and Health, Supplement;journal;03566528;0.22;Q3;23;20;30;299;12;27;0.4;14.95;Finland;Western Europe;Finnish Institute of Occupational Health;2005-2011, 2016-2018;"Geography, Planning and Development (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
373;5800173386;Current Drug Safety;journal;15748863;0.218;Q3;37;30;33;1789;23;33;0.7;59.63;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3); Toxicology (Q4)"
374;20684;Current Pharmacogenomics;journal;15701603;0.218;Q3;12;27;89;2689;55;89;0.67;99.59;Netherlands;Western Europe;Bentham Science Publishers B.V.;2004-2007;"Pharmacology (Q3); Genetics (Q4)"
375;19383;Fluoride - Quarterly Reports;journal;22534083, 00154725;0.216;Q4;48;33;130;755;138;124;1.08;22.88;New Zealand;Pacific Region;International Society for Fluoride Research;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3); Biochemistry (Q4); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
376;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.216;Q2;19;50;160;567;44;144;0.14;11.34;United States;Northern America;SAGE Publications Inc.;2000-2015, 2017-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Marketing (Q3); Medicine (miscellaneous) (Q3); Strategy and Management (Q3)"
377;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X, 15232859;0.215;Q3;20;57;197;482;113;196;0.65;8.46;United States;Northern America;Medical Letter Inc.;1965-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
378;25171;Mycotoxin Research;journal;18671632, 01787888;0.215;Q4;40;34;121;669;49;112;0.44;19.68;Germany;Western Europe;Springer-Verlag GmbH and Co. KG;1985-2021;"Biotechnology (Q3); Microbiology (Q4); Toxicology (Q4)"
379;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.214;Q3;22;42;93;968;26;93;0.24;23.05;India;Asiatic Region;Informatics Publishing Limited;2002-2021;Pharmacology (Q3)
380;130007;Drug Design Reviews Online;journal;15672697;0.213;Q3;10;0;48;0;22;48;0.46;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2005;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
381;16698;Revista Brasileira de Plantas Medicinais;journal;1983084X, 15160572;0.212;Q3;29;61;114;1863;26;114;0.2;30.54;Brazil;Latin America;Instituto de Biociencias;1999-2016;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
382;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.211;Q3;24;35;141;3958;60;126;0.4;113.09;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Immunology and Allergy (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4)"
383;16893;Biogenic Amines;journal;15693910, 01688561;0.211;Q3;15;31;76;1031;36;74;0.66;33.26;Slovenia;Eastern Europe;Society of Integrated Sciences;1989-2007;"Pharmacology (Q3); Neuroscience (miscellaneous) (Q4)"
384;4700152609;Current Computer-Aided Drug Design;journal;15734099;0.21;Q4;31;24;28;2269;16;26;0.57;94.54;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
385;73076;Drug Discovery World;journal;14694344;0.21;Q4;13;48;76;365;29;68;0.33;7.6;United Kingdom;Western Europe;RJ Communications and Media Ltd.;2004-2018;Drug Discovery (Q4)
386;4500151530;Personalized Medicine;journal;17410541;0.209;Q3;33;52;42;1997;22;36;0.52;38.4;United Kingdom;Western Europe;Future Medicine Ltd.;2006-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
387;21758;Prescrire International;journal;11677422;0.209;Q3;13;189;362;1404;99;230;0.33;7.43;France;Western Europe;Association Mieux Prescrire;1996-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
388;130006;Medicinal Chemistry Reviews - Online;journal;15672034;0.207;Q4;7;0;46;0;22;46;0.48;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2005;"Drug Discovery (Q4); Molecular Medicine (Q4)"
389;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.207;Q3;19;236;693;1006;77;675;0.13;4.26;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1961, 1973-2019;Pharmaceutical Science (Q3)
390;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.205;Q3;45;84;285;1672;88;285;0.23;19.9;Poland;Eastern Europe;Polish Pharmaceutical Society;1951-1955, 1961-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
391;144963;Drug Discovery Today: Disease Models;journal;17406757;0.205;Q4;28;36;175;1364;58;164;0.22;37.89;United Kingdom;Western Europe;Elsevier Ltd.;2004-2020;"Drug Discovery (Q4); Molecular Medicine (Q4)"
392;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.205;Q3;53;64;211;1465;105;178;0.39;22.89;India;Asiatic Region;Association of Physiologists and Pharmacologists of India;1959-2021;"Pharmacology (Q3); Physiology (Q4); Physiology (medical) (Q4)"
393;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.204;Q3;14;38;39;4108;8;34;0.21;108.11;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2018;"Endocrinology, Diabetes and Metabolism (Q3); Pharmacology (Q3); Immunology and Allergy (Q4)"
394;21102;Pharmaceutical Journal;journal;00316873;0.203;Q3;28;1013;6223;696;176;632;0.03;0.69;United Kingdom;Western Europe;Pharmaceutical Press;1945-1949, 1994-2012, 2014-2017;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
395;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.203;Q3;54;28;69;975;37;61;0.54;34.82;United States;Northern America;Elsevier Inc.;2005-2021;"Pharmacy (Q2); Pharmaceutical Science (Q3)"
396;25245;Veterinary and Human Toxicology;journal;01456296;0.203;Q4;41;0;114;0;119;108;0;0;United States;Northern America;Comparative Toxicology Laboratories;1977-2004;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4); Veterinary (miscellaneous) (Q4)"
397;21496;Revista de Chimie (discontinued);journal;00347752;0.202;-;31;293;789;4661;191;789;0.27;15.91;Romania;Eastern Europe;Syscom 18 SRL;1973, 1996-2021;Chemistry (miscellaneous) (Q3)
398;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.198;Q2;33;30;48;1058;52;45;1.08;35.27;Spain;Western Europe;Elsevier Espana;2005-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Agricultural and Biological Sciences (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q4)"
399;26653;Journal of Herbal Pharmacotherapy;journal;15229106, 15228940;0.198;Q3;29;31;80;902;49;74;0.46;29.1;United States;Northern America;The Haworth Herbal Press;2001-2008;"Pharmacology (Q3); Biochemistry (Q4)"
400;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0.195;Q4;32;51;60;1440;16;56;0.27;28.24;United Kingdom;Western Europe;Centro de Estudos de Venenos e Animais Peconhentos;2006-2021;"Animal Science and Zoology (Q4); Infectious Diseases (Q4); Parasitology (Q4); Toxicology (Q4)"
401;145096;Neuropsychopharmacologia Hungarica;journal;14198711;0.194;Q3;17;27;88;275;30;73;0.36;10.19;Hungary;Eastern Europe;Hungarian Association of Psychopharmacology;2004-2021;"Neurology (clinical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4)"
402;22854;Yakugaku Zasshi;journal;13475231, 00316903;0.194;Q3;43;246;346;6335;194;345;0.59;25.75;Japan;Asiatic Region;Pharmaceutical Society of Japan;1961-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
403;12328;Current Therapeutic Research;journal;0011393X, 18790313;0.189;Q3;42;38;128;1121;82;121;0.61;29.5;United States;Northern America;Elsevier Inc.;1959-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
404;19399;Acta Pharmaceutica Hungarica (discontinued);journal;00016659;0.188;Q3;14;30;74;778;15;74;0.15;25.93;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1965-2018;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3)"
405;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.188;Q3;25;16;27;571;8;25;0.3;35.69;Singapore;Asiatic Region;Elsevier;2005-2021;"Pharmacology (nursing) (Q2); Pharmaceutical Science (Q3); Sports Science (Q4)"
406;79053;Natural Product Sciences;journal;12263907;0.186;Q4;28;75;165;1686;49;165;0.26;22.48;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1997-2021;"Drug Discovery (Q4); Organic Chemistry (Q4)"
407;21077;Pharmaca;journal;00316857;0.184;Q3;5;16;35;308;14;33;0.38;19.25;Croatia;Eastern Europe;Udruzenje Organizacija Zdravstva Hrvatske;1989-2011;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
408;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.183;Q3;43;72;177;2184;69;168;0.42;30.33;Brazil;Latin America;Faculdade de Ciencias Farmaceuticas (Biblioteca-;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
409;35190;Revista Espanola de Quimioterapia;journal;02143429;0.179;Q3;26;52;146;1912;82;130;0.66;36.77;Spain;Western Europe;Sociedad Espanola de Quiminoterapia;1989-2021;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
410;20564;Ceska a Slovenska Farmacie;journal;12107816;0.176;Q3;17;45;156;1390;43;156;0.32;30.89;Czech Republic;Eastern Europe;Czech Medical Association J.E. Purkyne;1994-2021;Pharmaceutical Science (Q3)
411;23171;Korean Journal of Pharmacognosy;journal;02533073;0.174;Q3;17;71;178;1525;48;178;0.22;21.48;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1990-2011, 2013-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
412;21227;Pharmacy in Practice;journal;13581538;0.174;Q3;5;65;199;740;10;168;0.05;11.38;United Kingdom;Western Europe;Medicom Publishing;1995-2009;"Pharmacy (Q2); Health Policy (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
413;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115, 20082231;0.173;Q3;47;39;104;936;38;104;0.29;24;United Kingdom;Western Europe;BioMed Central Ltd.;2000-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
414;15842;Journal of Applied Research;journal;1537064X;0.173;Q3;22;28;184;731;63;178;0.4;26.11;United States;Northern America;The Journal of Applied Research;2001-2014;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
415;144613;Journal of Generic Medicines (discontinued);journal;17411343;0.173;Q3;15;41;135;311;25;117;0.15;7.59;United Kingdom;Western Europe;SAGE Publications Inc.;2003-2015, 2017, 2021;Pharmaceutical Science (Q3)
416;19700185200;Journal of Natural Medicines;journal;13403443, 18610293;0.173;Q3;50;91;163;1737;49;162;0.35;19.09;Germany;Western Europe;Springer Verlag;2006-2021;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Drug Discovery (Q4); Organic Chemistry (Q4)"
417;21127;Pharmaceutical Technology Europe;journal;01646826;0.172;Q3;18;99;295;813;40;180;0.14;8.21;United States;Northern America;Advanstar Communications Inc.;1998-2020;Pharmaceutical Science (Q3)
418;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.171;Q4;32;33;76;1165;38;74;0.55;35.3;United Kingdom;Western Europe;Informa Healthcare;1982-2000, 2005-2021;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
419;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.168;Q3;0;0;0;0;0;0;0;0;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
420;110097;Food and Drug Law Journal;journal;1064590X;0.168;Q3;22;42;101;3769;35;99;0.35;89.74;United States;Northern America;Food and Drug Law Institute;1992-2018, 2021;"Law (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3)"
421;22934;Chinese Pharmaceutical Journal;journal;10012494;0.167;Q3;21;445;1311;3997;211;1311;0.15;8.98;China;Asiatic Region;Chinese Pharmaceutical Association;1993-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
422;4700152903;Forensic Toxicology;journal;18608965, 18608973;0.167;Q4;39;20;47;331;23;45;0.55;16.55;Japan;Asiatic Region;Springer Japan;2006-2021;"Biochemistry (medical) (Q3); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
423;13718;Pharmaceutical Engineering;journal;02738139;0.167;Q3;16;58;166;368;15;149;0.07;6.34;United States;Northern America;Int. Society for Pharmaceutical Engineering, Inc.;1996-2018;Pharmaceutical Science (Q3)
424;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0.166;Q3;24;40;127;1040;45;127;0.28;26;United States;Northern America;Western Pharmacology Society;1960-1969, 1973-2011;Pharmacology (Q3)
425;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;0.16;Q4;28;27;27;2300;11;27;0.41;85.19;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2015;"Cardiology and Cardiovascular Medicine (Q3); Pharmacology (medical) (Q3); Drug Discovery (Q4)"
426;21795;Farmaceuticky Obzor (discontinued);journal;00148172;0.159;Q3;7;37;89;701;11;89;0.12;18.95;Slovakia;Eastern Europe;Postgraduate Medical and Pharmaceutical School;1961-1963, 1974, 1976-2016;Pharmaceutical Science (Q3)
427;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0.159;Q3;11;84;115;633;10;107;0.09;7.54;United States;Northern America;International Journal of Pharmaceutical Compounding;2006-2021;"Pharmacology (nursing) (Q2); Pharmacy (Q2); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
428;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.158;Q3;61;138;207;1366;147;199;0.71;9.9;China;Asiatic Region;Zhejiang University Press;2005-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Veterinary (miscellaneous) (Q4)"
429;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.158;Q3;10;34;61;595;7;60;0.11;17.5;Netherlands;Western Europe;IOS Press BV;1999, 2001-2002, 2005, 2007-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
430;19978;Ars Pharmaceutica (discontinued);journal;00042927;0.156;Q3;20;24;80;681;28;78;0.36;28.38;Spain;Western Europe;Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017, 2021;"History and Philosophy of Science (Q3); Pharmaceutical Science (Q3)"
431;4700152769;Pharmacopeial Forum (discontinued);journal;03634655;0.156;Q4;19;7;38;75;16;38;0.21;10.71;United States;Northern America;United States Pharmacopeial Convention Inc.;1996-1998, 2000-2018;"Pharmacy (Q2); Drug Guides (Q3); Pharmacology (Q4)"
432;21412;Zeitschrift fur Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.156;Q4;13;61;180;739;36;129;0.25;12.11;Germany;Western Europe;Hippokrates Verlag GmbH;1982, 1985-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
433;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.152;Q4;37;44;117;1458;34;117;0.28;33.14;Croatia;Eastern Europe;Institute for Medical Research and Occupational Health;1953-2021;"Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
434;18384;Medicinal Chemistry Research;journal;10542523, 15548120;0.152;Q3;50;48;275;1310;66;275;0.09;27.29;United States;Northern America;Birkhauser Boston;1994, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Organic Chemistry (Q4)"
435;22205;Saudi Pharmaceutical Journal;journal;13190164;0.152;Q3;57;27;75;1017;16;74;0.18;37.67;Saudi Arabia;Middle East;King Saud University;1996-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
436;22338;Hospital Pharmacy;journal;19451253, 00185787;0.15;Q4;24;141;420;1717;60;373;0.14;12.18;United States;Northern America;Thomas Land Publishers Inc.;1973-2021;"Pharmacology (medical) (Q3); Pharmacy (Q3); Pharmacology (Q4)"
437;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0.15;Q4;32;28;31;2317;7;30;0.23;82.75;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q4)"
438;21811;Farmacia Hospitalaria;journal;21718695, 11306343;0.149;Q4;24;82;237;1690;94;156;0.41;20.61;Spain;Western Europe;Grupo Aula Medica S.A.;1990-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q4)"
439;50105;Japanese Journal of Neuropsychopharmacology;journal;03887588, 13434144;0.149;Q4;11;30;114;932;23;114;0.15;31.07;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1982-1997, 2002-2017;"Pharmacology (medical) (Q3); Clinical Psychology (Q4); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
440;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0.148;Q3;59;126;47;6910;11;43;0.23;54.84;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Chemical Health and Safety (Q3); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Safety Research (Q3)"
441;145689;Alimentary Pharmacology and Therapeutics Symposium Series;journal;17466334;0.146;Q3;9;12;52;250;15;52;0.29;20.83;United Kingdom;Western Europe;;2005-2007;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
442;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.146;Q4;12;81;248;1341;46;247;0.2;16.56;China;Asiatic Region;Chinese Journal of Pharmacology and Toxicology;1986-2020;"Pharmacology (Q4); Toxicology (Q4)"
443;4700152608;African Journal of Traditional, Complementary and Alternative Medicines (discontinued);journal;25050044, 01896016;0.145;Q4;48;73;53;1686;22;52;0.42;23.1;Nigeria;Africa;African Ethnomedicines Network;2006-2017;"Complementary and Alternative Medicine (Q3); Medicine (miscellaneous) (Q3); Drug Discovery (Q4)"
444;6400153120;Chinese Medicine;journal;17498546;0.145;Q4;45;13;4;867;2;3;0.5;66.69;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
445;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0.145;Q3;28;32;33;803;8;33;0.24;25.09;Spain;Western Europe;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3)"
446;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.144;Q3;20;25;69;578;9;68;0.02;23.12;Turkey;Middle East;Istanbul Medipol University;2006-2011, 2016-2021;Pharmaceutical Science (Q3)
447;4100151616;Supportive Cancer Therapy;journal;15432912;0.143;Q4;14;28;38;746;7;29;0.18;26.64;United States;Northern America;Cancer Information Group, LP;2006-2007;"Oncology (Q3); Cancer Research (Q4); Pharmacology (Q4)"
448;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.141;Q3;27;51;161;1323;48;156;0.34;25.94;France;Western Europe;Elsevier Masson s.r.l.;1945, 1947-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
449;145693;Canadian Pharmacists Journal;journal;17151635;0.141;Q3;24;138;442;742;27;248;0.07;5.38;Canada;Northern America;Canadian Pharmacists Association;2005-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3)"
450;19700180827;Progress in Pharmaceutical and Biomedical Analysis;book series;14643456;0.14;Q3;8;0;14;0;5;12;0.36;0;United Kingdom;Western Europe;Elsevier Ltd.;1994, 1996, 2000, 2003, 2005;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Biotechnology (Q4)"
451;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.14;Q3;32;540;1179;5880;272;1179;0.21;10.89;China;Asiatic Region;Zhongguo Zhongyi Yanjiuyuan;1989-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
452;130170;Phytotherapie;journal;17652847, 16248597;0.139;Q4;18;76;100;839;5;68;0.05;11.04;France;Western Europe;Springer Paris;2005-2020;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
453;3300147901;EMC - Toxicologie-Pathologie;journal;17625858;0.137;Q4;6;0;30;0;8;29;0.36;0;France;Western Europe;Editions scientifique et medicales Elsevier SAS;2004-2005;"Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
454;10300153342;Journal of Medical Toxicology;journal;15569039, 19376995;0.137;Q4;52;37;49;103;8;40;0.16;2.78;United States;Northern America;Springer New York;2005-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
455;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.136;Q3;10;36;117;324;10;117;0.1;9;France;Western Europe;Editions de Sante;1991-2014, 2017-2018;Pharmaceutical Science (Q3)
456;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.135;Q3;13;73;232;786;39;192;0.2;10.77;Germany;Western Europe;Wiley-VCH Verlag;1972-2012;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
457;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.134;Q3;42;60;115;376;35;114;0.3;6.27;Pakistan;Asiatic Region;Pakistan Journal of Pharmaceutical Sciences;1995, 2005-2021;Pharmaceutical Science (Q3)
458;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.134;Q3;18;45;110;1467;12;107;0.11;32.6;Brazil;Latin America;Universidade Estadual Paulista - UNESP;2005-2021;Pharmaceutical Science (Q3)
459;25197;Revista de Toxicologia (discontinued);journal;02127113;0.134;Q4;11;12;59;259;13;59;0.14;21.58;Spain;Western Europe;Asociacion Espanola de Toxicologia;1989-2017, 2020;Toxicology (Q4)
460;23173;Korean Journal of Physiology and Pharmacology;journal;20933827, 12264512;0.133;Q4;33;39;155;1294;17;155;0.14;33.18;South Korea;Asiatic Region;Korean Physiological Soc. and Korean Soc. of Pharmacology;1997-2021;"Pharmacology (Q4); Physiology (Q4)"
461;3900148201;International Journal of Pharmacology (discontinued);journal;18125700, 18117775;0.132;Q4;39;92;128;2520;33;128;0.26;27.39;Pakistan;Asiatic Region;Asian Network for Scientific Information;2006-2018, 2020-2021;Pharmacology (Q4)
462;22979;Journal of Applied Therapeutic Research;journal;10292659;0.132;Q4;8;4;34;93;9;34;0.07;23.25;United Kingdom;Western Europe;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
463;23107;Journal of Pharmacy Technology;journal;15494810, 87551225;0.132;Q3;13;31;123;712;14;103;0.13;22.97;United States;Northern America;SAGE Publications Inc.;1989-2021;Pharmaceutical Science (Q3)
464;19700189100;Pharmaceutical Medicine;journal;11782595, 11791993;0.131;Q4;19;59;112;1291;17;95;0.18;21.88;United Kingdom;Western Europe;Adis International Ltd;2000-2001, 2008-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
465;19982;Asia Pacific Journal of Pharmacology;journal;02179687;0.13;Q4;9;0;21;0;10;20;0;0;Singapore;Asiatic Region;Singapore University Press;1986-1998, 2000-2001, 2003-2004, 2006;Pharmacology (Q4)
466;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.13;Q4;29;11;55;403;10;55;0.17;36.64;United States;Northern America;Taylor and Francis Ltd.;1992-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
467;4000151610;International Journal of Neuroprotection and Neuroregeneration;journal;17451183, 17451191;0.127;Q4;5;18;26;590;8;24;0.31;32.78;United Kingdom;Western Europe;RPA Publishers.;2006-2008;"Neurology (clinical) (Q4); Pharmacology (Q4)"
468;15240;Iranian Journal of Medical Sciences;journal;17353688, 02530716;0.127;-;31;60;168;1163;18;154;0.1;19.38;Iran;Middle East;Shiraz University of Medical Sciences;1979-1981, 1989-2021;Medicine (miscellaneous) (Q3)
469;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.126;Q3;9;39;106;636;9;103;0.13;16.31;Cuba;Latin America;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3); Pharmacology (Q4)"
470;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.125;Q4;19;140;343;2510;51;332;0.07;17.93;Japan;Asiatic Region;Japanese Pharmacological Society;1944, 1947-1948, 1951-1956, 1958-2021;Pharmacology (Q4)
471;10900153328;Frontiers in Drug Design and Discovery;book series;15740889, 22121064;0.124;Q4;9;23;18;2910;5;17;0.28;126.52;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2007, 2009, 2016-2018;"Drug Discovery (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4)"
472;23074;Journal of Pharmaceutical Finance, Economics and Policy;journal;15385396, 15385698;0.124;Q4;7;16;49;871;8;42;0.14;54.44;United States;Northern America;Haworth Press Inc.;2003-2008;"Health Policy (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
473;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.124;Q4;34;155;482;2524;51;482;0.1;16.28;United States;Northern America;Springer New York;1967-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
474;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.124;Q4;14;22;33;276;0;30;0;12.55;Cuba;Latin America;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-2020;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
475;5100152606;Biosciences Biotechnology Research Asia (discontinued);journal;09731245;0.123;Q4;18;144;195;2362;8;194;0.04;16.4;India;Asiatic Region;Oriental Scientific Publishing Company;2005-2016;"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
476;21716;Pharmazeutische Zeitung;journal;00317136;0.123;Q4;7;451;1379;1071;11;637;0.01;2.37;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
477;17716;Quality Assurance Journal;journal;10991786, 10878378;0.123;Q4;9;26;95;167;13;84;0.2;6.42;United Kingdom;Western Europe;John Wiley and Sons Ltd;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
478;21329;European Journal of Herbal Medicine;journal;13524755;0.122;Q4;2;0;5;0;0;1;0;0;United Kingdom;Western Europe;National Institute of Medical Herbalists Ltd;2001-2004;Pharmacology (Q4)
479;19700201521;Journal of Chemical and Pharmaceutical Research (discontinued);journal;09757384;0.122;Q4;39;0;1;0;0;1;0;0;India;Asiatic Region;JOCPR;2004, 2011-2016;Pharmaceutical Science (Q4)
480;15892;Journal of Drug Evaluation;journal;14791137;0.121;Q4;4;0;24;0;3;10;0;0;United Kingdom;Western Europe;Parthenon Publishing Group;2003-2004;"Pharmacology (Q4); Pharmacy (Q4)"
481;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.121;Q4;9;34;89;883;5;68;0.08;25.97;Mexico;Latin America;Asociacion Farmaceutica Mexicana A.C.;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
482;130150;Advances in Pharmacy;journal;15323862;0.12;Q4;2;0;25;0;2;16;0.08;0;United States;Northern America;Facts and Comparisons;2005;Pharmaceutical Science (Q4)
483;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.12;Q4;18;24;89;877;11;85;0.1;36.54;Turkey;Middle East;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-2021;Pharmaceutical Science (Q4)
484;130031;Journal of Toxicologic Pathology;journal;09149198;0.12;Q4;30;24;93;891;13;93;0.19;37.13;Japan;Asiatic Region;Japanese Society of Toxicologic Pathology;1988-1990, 1992-2021;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
485;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;journal;18715125;0.12;Q4;21;6;23;121;3;21;0.13;20.17;United States;Northern America;Academic Press Inc.;2001-2003, 2005, 2007-2021;"Medicine (miscellaneous) (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
486;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.12;Q4;14;21;53;28;11;53;0.15;1.33;Japan;Asiatic Region;Nihon Sangyo Eisei Gakkai;1995-2021;"Medicine (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
487;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.119;Q4;16;100;219;1493;14;219;0.08;14.93;Japan;Asiatic Region;Life Science Publishing Co. Ltd;1981-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
488;80593;Journal of Medicinal Plants;journal;16840240;0.118;Q4;23;53;125;1155;9;125;0.04;21.79;Iran;Middle East;;2004-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
489;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0.117;Q4;17;392;241;4378;30;241;0.12;11.17;China;Asiatic Region;Editorial Office of Chinese Traditional and Herbal Drugs;2006-2021;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
490;25196;Revista Brasileira de Toxicologia;journal;14152983;0.117;Q4;7;9;34;363;1;33;0.04;40.33;Brazil;Latin America;Sociedade Brasileira de Toxicologia;2000-2010;Toxicology (Q4)
491;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.116;Q4;14;55;113;766;6;112;0.07;13.93;United Kingdom;Western Europe;Taylor and Francis Ltd.;1992, 2004-2013, 2015-2019;"Demography (Q4); Environmental Science (miscellaneous) (Q4); Toxicology (Q4)"
492;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.116;Q4;15;93;322;2092;37;322;0.13;22.49;Russian Federation;Eastern Europe;Izdatelstvo Meditsina;1992-2021;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
493;20572;PZ Prisma;journal;09455566;0.116;Q4;5;34;101;705;4;88;0.05;20.74;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1994-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
494;22887;Chinese Journal of Antibiotics;journal;10018689;0.115;Q4;11;176;592;2455;35;585;0.06;13.95;China;Asiatic Region;Editorial Office of Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
495;22514;Japanese Journal of Chemotherapy;journal;13407007;0.115;Q4;12;44;188;725;12;188;0.05;16.48;Japan;Asiatic Region;Japan Society of Chemotherapy;1995-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
496;144879;Toxicology International;journal;09716580;0.115;Q4;28;26;39;520;5;39;0.13;20;India;Asiatic Region;Society of Toxicology India;2005-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
497;86688;Acta Toxicologica;journal;17316383;0.114;Q4;7;21;50;497;3;47;0.09;23.67;Poland;Eastern Europe;Nofer Institute of Occupational Medicine;2003-2007;Toxicology (Q4)
498;19430;Adverse Drug Reaction Bulletin;journal;21597774, 00446394;0.114;Q4;7;6;18;245;5;18;0.17;40.83;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1970, 1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
499;70864;Anales de la Real Academia Nacional de Farmacia (discontinued);journal;1697428X, 16974271;0.114;Q4;10;52;104;2104;10;102;0.09;40.46;Spain;Western Europe;Real Academia Nacional de Farmacia;1988-2018;"Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
500;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.113;Q4;5;52;96;527;2;96;0.02;10.13;Bulgaria;Eastern Europe;PHARMAKON-Press;1989-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
501;21142;Pharmaceutisch Weekblad;journal;00316911;0.113;Q4;9;440;1772;407;14;1161;0.01;0.93;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);1948-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
502;21867;Geneesmiddelenbulletin;journal;03044629;0.112;Q4;7;70;196;180;5;33;0.03;2.57;Netherlands;Western Europe;Stichting Geneesmiddelenbulletin;1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
503;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.112;Q4;6;35;127;164;5;118;0.01;4.69;United States;Northern America;Russell Publishing LLC;2010-2018, 2021;"Health Policy (Q4); Pharmaceutical Science (Q4)"
504;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0.112;Q4;16;15;15;365;2;15;0.13;24.33;Turkey;Middle East;Turkish Pharmacists  Association;2006-2021;"Molecular Medicine (Q4); Pharmaceutical Science (Q4)"
505;4100151606;Actualites Pharmaceutiques Hospitalieres;journal;17697344;0.111;Q4;3;51;73;188;2;64;0.03;3.69;France;Western Europe;Elsevier Masson s.r.l.;2005-2012;Pharmaceutical Science (Q4)
506;19400157142;Chiang Mai University Journal of Natural Sciences;journal;16851994;0.111;-;12;0;2;0;0;2;0;0;Thailand;Asiatic Region;Chiang Mai University;2003, 2006, 2009-2021;Multidisciplinary (Q4)
507;15680;Giornale di Neuropsicofarmacologia;journal;19711387, 03919048;0.111;Q4;1;12;65;129;1;57;0.02;10.75;Italy;Western Europe;CIC Edizioni Internazionali s.r.l.;1996-2008;"Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
508;89630;Psychopharmakotherapie, Supplement;journal;09465146;0.111;Q4;2;10;37;112;2;30;0.07;11.2;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;1997-1999, 2004-2005, 2007-2008;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
509;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;0.111;Q4;47;0;2;0;0;2;0;0;India;Asiatic Region;A and V Publication;1997, 2005, 2011-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
510;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.11;Q4;17;8;38;172;4;36;0.13;21.5;United States;Northern America;Informa Healthcare;1983-1990, 1992-2016;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
511;4000151703;Core Evidence (discontinued);journal;15551741, 1555175X;0.11;Q4;25;10;20;726;3;19;0.15;72.6;New Zealand;Pacific Region;Dove Medical Press Ltd.;2005-2018;"Reviews and References (medical) (Q1); Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
512;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.11;Q4;3;112;282;250;3;255;0.01;2.23;United Kingdom;Western Europe;Samedan Ltd;2002-2016;Pharmaceutical Science (Q4)
513;22977;Journal de Pharmacie de Belgique;journal;00472166;0.11;Q4;12;32;59;498;8;59;0.22;15.56;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
514;20661;Current Drug Discovery;journal;14727463;0.109;Q4;12;0;97;0;11;52;0;0;United Kingdom;Western Europe;Current Drugs Ltd.;2002-2004;Pharmacology (Q4)
515;9100153105;Current Topics in Pharmacology;journal;09724559;0.108;Q4;6;18;18;1118;2;18;0.11;62.11;India;Asiatic Region;Research Trends;2006-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
516;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.107;Q4;34;13;50;0;3;50;0.06;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
517;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.107;Q4;5;93;274;534;6;248;0.03;5.74;United Kingdom;Western Europe;Samedan Ltd;2004-2019;Pharmaceutical Science (Q4)
518;11100153314;Frontiers in Medicinal Chemistry;book series;18755763, 15742042;0.107;Q4;7;0;27;0;5;26;0.19;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006, 2009-2010;"Drug Discovery (Q4); Molecular Medicine (Q4); Organic Chemistry (Q4)"
519;20628;Circular Farmaceutica;journal;00097314;0.106;Q4;3;40;121;322;3;107;0.04;8.05;Spain;Western Europe;Col-legi de Farmaceutics de la Provincia de Barcelona;1961, 1973-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
520;19700188399;Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.];journal;19349254, 19349262;0.106;Q4;28;17;53;0;5;53;0.14;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
521;58808;Pharmaceutical Care and Research;journal;16712838;0.106;Q4;8;126;319;1163;9;316;0.02;9.23;China;Asiatic Region;Publishing House of Pharmaceutical Care and Research;2004-2021;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
522;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074, 09728066;0.105;Q4;11;11;46;201;4;32;0;18.27;India;Asiatic Region;Anil Aggrawal;2000-2020;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
523;88685;Annual Report of Shionogi Research Laboratory;journal;05598680;0.105;Q4;2;2;4;180;0;4;0;90;Japan;Asiatic Region;Shionogi Co. Ltd;1972-1974, 1987-2009, 2015;Pharmacology (Q4)
524;5200152843;Farmaceutico Hospitales;journal;02144697;0.105;Q4;3;45;8;520;0;4;0;11.56;Spain;Western Europe;Ediciones Mayo S.A.;2006-2012;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
525;17700156431;Handbook of Analytical Separations;book series;15677192;0.105;Q4;12;0;14;0;2;0;0;0;Netherlands;Western Europe;Elsevier;2000-2001, 2003-2004, 2008, 2020;"Analytical Chemistry (Q4); Environmental Chemistry (Q4); Pathology and Forensic Medicine (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
526;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185, 22312730;0.105;Q4;35;95;300;1386;7;214;0.03;14.59;India;Asiatic Region;Wolters Kluwer Medknow Publications;1996-1999, 2002-2021;"Anesthesiology and Pain Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
527;17783;Research Communications in Molecular Pathology and Pharmacology;journal;10780297;0.105;Q4;39;11;44;0;2;44;0;0;United States;Northern America;PJD Publications Ltd;1994-2007, 2009;"Medicine (miscellaneous) (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
528;19600162009;Advances in Molecular Toxicology;book series;18720854, 22122044;0.104;Q4;15;0;6;0;0;5;0;0;Netherlands;Western Europe;Elsevier;2006, 2008-2018, 2020;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
529;21238;Drug Topics;journal;19378157, 00126616;0.104;Q4;8;358;1566;0;17;1333;0.01;0;United States;Northern America;Advanstar Communications Inc.;1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
530;72164;Journal of Infectious Disease Pharmacotherapy;journal;10687777;0.104;Q4;6;0;6;0;0;6;0;0;United States;Northern America;Pharmaceutical Products Press;1996, 1998-1999, 2001-2004;"Microbiology (medical) (Q4); Pharmacology (Q4)"
531;21083;Pharmaceutical Care Espana (discontinued);journal;11396202;0.104;Q4;9;26;89;464;25;76;0.2;17.85;Spain;Western Europe;Fundacion Pharamaceutical Care Espana;2001-2017;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
532;19700175108;Drug Delivery System;journal;18812732, 09135006;0.103;Q4;8;30;116;570;5;116;0.06;19;Japan;Asiatic Region;Japan Society of Drug Delivery System;1986, 1988-2021;Pharmaceutical Science (Q4)
533;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.103;Q4;7;290;512;2636;10;512;0.02;9.09;China;Asiatic Region;Jilin University Press;2005-2021;Pharmacology (Q4)
534;19700180757;Advances in Phytomedicine;book series;1572557X;0.102;Q4;13;0;43;0;2;39;0.05;0;Netherlands;Western Europe;Elsevier;2002, 2006;"Drug Discovery (Q4); Plant Science (Q4)"
535;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.102;Q4;11;15;62;395;5;62;0;26.33;Turkey;Middle East;University of Ankara;1997-2001, 2003-2010, 2014, 2016-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
536;21932;Hindustan Antibiotics Bulletin;journal;00181935;0.102;Q4;9;7;9;0;0;9;0;0;India;Asiatic Region;Hindustan Antibiotics Ltd.;1960-1961, 1965-2000, 2002-2003, 2005, 2007, 2009;Pharmacology (Q4)
537;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.102;Q4;0;0;0;0;0;0;0;0;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1981-2016;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
538;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.102;Q4;10;0;49;0;6;46;0.13;0;Netherlands;Western Europe;Brill Academic Publishers;1995, 1997, 2001, 2004-2006, 2008-2011, 2013-2021;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
539;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0.102;Q4;9;14;11;169;0;11;0;12.07;Turkey;Middle East;University of Istanbul;2005, 2007-2008, 2010, 2012, 2015-2016;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
540;13637;Manufacturing Chemist;trade journal;02624230;0.102;Q4;6;79;10;126;0;9;0;1.59;United Kingdom;Western Europe;Wilmington Publishing;1981-1984, 1986, 1989, 1996-2001, 2006-2021;Pharmaceutical Science (Q4)
541;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X;0.101;Q4;10;0;0;0;0;0;0;0;Poland;Eastern Europe;Uniwersytet Medyczny w Lublinie;2012-2021;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
542;4700152278;Drugs in Context;journal;17404398, 17451981;0.101;Q4;26;11;48;265;0;36;0;24.09;United Kingdom;Western Europe;BioExcel Publishing Ltd.;2006-2008, 2012-2021;"Molecular Medicine (Q4); Pharmacology (Q4)"
543;144718;Enhancer - Biotherapy of Cancer;journal;15720004;0.101;Q4;0;0;43;0;0;21;0;0;Netherlands;Western Europe;;2005-2006;"Cancer Research (Q4); Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Oncology (Q4)"
544;20778;EOS Rivista di Immunologia ed Immunofarmacologia;journal;03926699;0.101;Q4;5;0;17;0;0;17;0;0;Italy;Western Europe;Sigma-Tau SpA;1983-2001, 2003-2004;"Immunology (Q4); Pharmacology (Q4)"
545;19700180822;Immunotoxicology of Drugs and Chemicals: an Experimental and Clinical Approach;book series;18739822;0.101;Q4;2;0;17;0;2;16;0;0;Netherlands;Western Europe;Elsevier;2004;"Immunology (Q4); Toxicology (Q4)"
546;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.101;Q4;9;27;31;348;3;31;0.1;12.89;India;Asiatic Region;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-2021;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
547;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;0.101;Q4;21;39;31;1121;2;31;0.06;28.74;Iran;Middle East;Academy of Medical Sciences of I.R. Iran;2006-2015;Pharmacology (Q4)
548;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;18828272, 03881601;0.101;Q4;7;13;181;180;3;170;0.02;13.85;Japan;Asiatic Region;Japanese Society of Clinical Pharmacology and Therapeutics;1970-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
549;21823;Pharmacia;journal;04280296;0.101;Q4;16;13;106;238;4;106;0.04;18.31;Bulgaria;Eastern Europe;Pensoft Publishers;1945, 1954-1955, 1987-1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
550;20543;Pharmacometrics;journal;03008533;0.101;Q4;6;0;33;0;0;33;0;0;Japan;Asiatic Region;Japanese Society of Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
551;5000158120;Pharmacy News;journal;1448207X;0.101;Q4;1;326;72;27;0;24;0;0.08;United Kingdom;Western Europe;Reed Business Publishing;2006-2009;"Pharmacology (nursing) (Q3); Pharmaceutical Science (Q4)"
552;5200152604;Pharma Times;journal;00316849;0.101;Q4;12;71;25;512;0;22;0;7.21;India;Asiatic Region;Indian Pharmaceutical Association;2006-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
553;145000;Signal;journal;14719967;0.101;Q4;1;5;29;131;1;16;0.03;26.2;United Kingdom;Western Europe;Adis International Ltd;2005-2007;"Drug Discovery (Q4); Oncology (Q4); Pharmacology (medical) (Q4)"
554;19408;Actualites Pharmaceutiques;journal;05153700;0.1;Q4;5;197;491;143;0;345;0;0.73;Netherlands;Western Europe;Elsevier;1961, 1963, 1996-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
555;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.1;Q4;6;40;132;96;3;132;0;2.4;Spain;Western Europe;Real Academia de Farmacia;1949-2012, 2014;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
556;9500153932;Ciencia y Tecnologia Pharmaceutica;journal;15753409;0.1;Q4;6;6;74;55;3;62;0.06;9.17;Spain;Western Europe;Fundacion Alimentacion Saludable;1996-2007;Pharmacology (Q4)
557;5100154302;European Biotechnology Science and Industry News;journal;16188276;0.1;Q4;2;92;70;48;0;64;0;0.52;Germany;Western Europe;Biocom AG;2006-2013;"Biotechnology (Q4); Drug Discovery (Q4)"
558;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.1;Q4;3;25;41;259;0;39;0;10.36;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
559;21798;Farmaceutski Glasnik;journal;00148202;0.1;Q4;6;19;48;452;1;48;0;23.79;Croatia;Eastern Europe;Hrvatsko Farmaceutsko Drustvo;1950-1951, 1962, 1990-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
560;21800;Farmacevtski Vestnik (discontinued);journal;00148229;0.1;Q4;4;30;81;647;0;80;0;21.57;Slovenia;Eastern Europe;Slovenian Pharmaceutical Society;1961, 1989-2016;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
561;11800154521;ICBPE 2006 - Proceedings of the 2006 International Conference on Biomedical and Pharmaceutical Engineering;conference and proceedings;-;0.1;-;9;0;124;0;8;123;0.06;0;United States;Northern America;;;"Biomedical Engineering; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
562;19700174971;Indian Journal of Forensic Medicine and Toxicology (discontinued);journal;09739122, 09739130;0.1;Q4;12;0;0;0;0;0;0;0;India;Asiatic Region;Institute of Medico-legal Publications;2008-2021;"Health, Toxicology and Mutagenesis (Q4); Law (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
563;4900152705;NATO Security through Science Series A: Chemistry and Biology;book series;18714641;0.1;Q4;14;148;41;2649;1;41;0.02;17.9;Germany;Western Europe;Springer Verlag;2006-2008;"Biotechnology (Q4); Chemistry (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
564;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.1;Q4;5;12;40;217;0;40;0;18.08;Japan;Asiatic Region;Japanese Society of Oral Therapeutics and Pharmacology;1982-2021;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
565;72755;Phytomedica;journal;09723293;0.1;Q4;4;15;55;208;1;55;0;13.87;India;Asiatic Region;Society of Phytomedica;1999-2008;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
566;5800207507;Side Effects of Drugs Annual;book series;03786080;0.1;Q4;6;51;101;3531;1;52;0.02;69.24;Netherlands;Western Europe;Elsevier;1977-1995, 1997-2005, 2007-2012, 2014-2020;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
567;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790, 21684804;0.1;Q4;46;85;241;1294;104;231;0.5;15.22;United States;Northern America;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4)"
568;12000154522;Advances in Antiviral Drug Design;book series;10758593;;-;12;7;0;624;0;0;0;89.14;United Kingdom;Western Europe;Elsevier Ltd.;1996, 1999, 2003, 2007;"Infectious Diseases; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Virology"
569;5400152620;American Journal of Pharmacology and Toxicology (discontinued);journal;15574970, 15574962;;-;21;21;0;581;0;0;0;27.67;United States;Northern America;Science Publications;2007-2016;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
570;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;;-;8;26;0;874;0;0;0;33.62;Venezuela;Latin America;Sociedad Latinoamericana de Hipertension;2007-2013, 2015-2021;"Pharmacology; Pharmacology (medical)"
571;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;;-;5;105;0;1399;0;0;0;13.32;China;Asiatic Region;China Pharmaceutical University;2007-2021;"Applied Microbiology and Biotechnology; Pharmaceutical Science"
572;5800173401;Current Bioactive Compounds;journal;15734072;;-;27;17;0;1782;0;0;0;104.82;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
573;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;;-;30;70;0;2379;0;0;0;33.99;United States;Northern America;Current Medicine Group;2007-2021;"Pharmacology; Pharmacology (medical)"
574;5800173394;Current Drug Therapy;journal;15748855;;-;17;30;0;2159;0;0;0;71.97;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
575;21101055116;Current Reviews in Clinical and Experimental Pharmacology;journal;27724328, 27724336;;-;43;23;28;2501;19;28;0.68;108.74;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
576;13000154717;Current Topics in Toxicology;journal;09728228;;-;7;7;0;326;0;0;0;46.57;India;Asiatic Region;Research Trends;2007-2009, 2011-2021;"Health, Toxicology and Mutagenesis; Toxicology"
577;19700174893;Dhaka University Journal of Pharmaceutical Sciences (discontinued);journal;18161839, 18161820;;-;13;26;0;310;0;0;0;11.92;Bangladesh;Asiatic Region;University of Dhaka;2007-2018, 2020;"Pharmaceutical Science; Pharmacology (medical)"
578;11200153563;Drug Metabolism Letters;journal;18740758, 18723128;;-;28;53;0;136;0;0;0;2.57;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2019, 2021;"Biochemistry (medical); Clinical Biochemistry; Pharmaceutical Science; Pharmacology (medical)"
579;21100938253;Environmental Pollutants and Bioavailability;journal;26395940, 26395932;;-;33;17;48;638;39;48;0.83;37.53;United Kingdom;Western Europe;Taylor and Francis Ltd.;2019-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
580;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;;-;9;72;0;241;0;0;0;3.35;United Kingdom;Western Europe;Samedan Ltd;2007-2010, 2012-2019;Pharmaceutical Science
581;6800153106;International Journal of Essential Oil Therapeutics;journal;19614209;;-;13;32;0;1041;0;0;0;32.53;France;Western Europe;Essential Oil Resource Consultants;2007-2010;"Complementary and Alternative Medicine; Pharmaceutical Science; Pharmacology (medical)"
582;19700174628;Iranian Journal of Basic Medical Sciences;journal;20083874, 20083866;;-;44;16;0;414;0;0;0;25.88;Iran;Middle East;Mashhad University of Medical Sciences;2007-2021;"Biochemistry; Biophysics; Clinical Biochemistry; Drug Discovery; Immunology and Microbiology (miscellaneous) "
583;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;;-;48;37;125;748;27;114;0.15;20.22;Iran;Middle East;Iranian Journal of Pharmaceutical Research;2002-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
584;21100301409;Issues in Toxicology;book series;17577179, 17577187;;-;16;26;0;1135;0;0;0;43.65;United Kingdom;Western Europe;Royal Society of Chemistry;2007-2021;"Health, Toxicology and Mutagenesis; Pharmacology; Toxicology"
585;11700154733;Journal of Biomedical Nanotechnology;journal;15507041, 15507033;;-;80;51;0;1989;0;0;0;39;United States;Northern America;American Scientific Publishers;2007-2020;"Bioengineering; Biomedical Engineering; Materials Science (miscellaneous); Medicine (miscellaneous); Nanoscience and Nanotechnology; Pharmaceutical Science"
586;27767;Journal of Forensic Medicine and Toxicology;journal;09711929;;-;18;29;43;369;2;43;0.06;12.72;India;Asiatic Region;;1997-2020;"Pathology and Forensic Medicine; Toxicology"
587;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;;-;6;9;0;180;0;0;0;20;Nigeria;Africa;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009, 2015-2016;Pharmacology
588;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;26;142;284;3418;84;284;0.25;24.07;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-2021;"Drug Discovery; Pharmaceutical Science"
589;24071;Metal-Based Drugs;journal;07930291, 16875486;;-;38;5;0;133;0;0;0;26.6;United States;Northern America;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Drug Discovery; Inorganic Chemistry; Pharmacology; Toxicology"
590;5400152706;Nanotoxicology;journal;17435390, 17435404;;-;94;26;0;1367;0;0;0;52.58;United Kingdom;Western Europe;Informa Healthcare;2007-2021;"Biomedical Engineering; Nanoscience and Nanotechnology; Toxicology"
591;19700175819;Patient Preference and Adherence;journal;1177889X;;-;54;18;0;571;0;0;0;31.72;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Health Policy; Medicine (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Social Sciences (miscellaneous)"
592;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;;-;6;15;0;441;0;0;0;29.4;Switzerland;Western Europe;Springer Science + Business Media;2007-2018;"Health Policy; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
593;5800179590;Pharmacologyonline (discontinued);journal;18278620;;-;27;157;0;3857;0;0;0;24.57;Italy;Western Europe;SILAE - Societa Italo-Latinoamericana di Etnomedicina;2007-2021;"Drug Discovery; Pharmacology"
594;21243;Pharmacy Times;trade journal;00030627;;-;8;256;0;1539;0;0;0;6.01;United States;Northern America;Intellisphere LLC;1977-1987, 2007-2021;"Pharmaceutical Science; Pharmacology; Pharmacy"
595;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;;-;143;41;0;1123;0;0;0;27.39;United States;Northern America;Public Library of Science;2007-2021;"Infectious Diseases; Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Public Health, Environmental and Occupational Health"
596;21101055117;Recent Advances in Anti-Infective Drug Discovery;journal;27724352, 27724344;;-;33;22;30;2265;26;30;0.87;102.95;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Drug Discovery; Infectious Diseases; Pharmacology (medical)"
597;11500153306;Recent Patents on Drug Delivery and Formulation;journal;22124039, 18722113;;-;36;22;0;1672;0;0;0;76;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Biomedical Engineering; Medicine (miscellaneous); Pharmaceutical Science"
598;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X, 22122710;;-;29;28;0;2149;0;0;0;76.75;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Drug Discovery; Immunology and Allergy; Medicine (miscellaneous)"
599;5400152628;Revista Brasileira de Farmacognosia;journal;0102695X, 1981528X;;-;50;93;0;2875;0;0;0;30.91;Brazil;Latin America;Springer Nature Switzerland AG;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
600;10300153375;Taiwan Pharmaceutical Journal;journal;10161015;;-;5;25;0;417;0;0;0;16.68;Taiwan;Asiatic Region;Pharmaceutical Society of Republic of China;2007, 2009;"Pharmaceutical Science; Pharmacology"
601;9800153137;Trastornos Adictivos;journal;15750973;;-;9;32;0;799;0;0;0;24.97;Spain;Western Europe;Ediciones Doyma, S.L.;2007-2012;"Pharmacology; Psychiatry and Mental Health"
602;22358;U.S. Pharmacist;trade journal;01484818;;-;9;171;0;3307;0;0;0;19.34;United States;Northern America;Jobson Publishing Corporation;1979, 1990-1996, 2007-2021;"Pharmaceutical Science; Pharmacology; Pharmacy"
